data_6vgp_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6vgp _Structure_validation_residue.Date_analyzed 2020-07-03 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.512 ' O ' ' HB2' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.4 mmt85 -64.61 -41.5 96.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.833 0.349 . . . . 0.0 110.629 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.532 ' CG2' ' HA ' ' A' ' 7' ' ' PRO . 84.8 mt -72.29 -4.6 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.75 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 99.2 m-20 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.377 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.523 ' O ' HG22 ' A' ' 3' ' ' ILE . 9.5 p . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.848 0.356 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.532 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 49.1 Cg_endo -72.09 43.42 0.59 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.692 2.261 . . . . 0.0 111.878 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -114.11 -30.58 6.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.428 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.4 ' O ' HG12 ' A' ' 3' ' ' ILE . . . -167.86 161.1 34.87 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.507 ' HA2' ' CG1' ' A' ' 3' ' ' ILE . . . -64.69 -31.75 81.95 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.393 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.657 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.633 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 78.9 mm-40 . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 120.746 0.308 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 . . . . . 0 C--N 1.332 -0.18 0 CA-C-O 120.896 0.379 . . . . 0.0 110.417 179.779 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.633 ' SG ' ' N ' ' A' ' 14' ' ' GLU . 12.6 p . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.461 0.172 . . . . 0.0 111.315 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.313 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.574 ' O ' ' OD1' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.493 ' HB3' ' CA ' ' A' ' 10' ' ' GLY . 84.3 mtp180 -61.95 -36.2 80.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.832 0.348 . . . . 0.0 110.594 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.585 HD11 ' N ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -52.7 -36.66 23.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.516 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.574 ' OD1' ' O ' ' A' ' 1' ' ' GLY . 90.1 m-20 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.629 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.454 ' O ' ' HB ' ' A' ' 3' ' ' ILE . 22.5 p . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.793 0.33 . . . . 0.0 110.572 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -78.5 18.33 0.97 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.918 2.412 . . . . 0.0 112.175 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -85.92 -42.38 14.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.614 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.4 171.99 44.28 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.493 ' CA ' ' HB3' ' A' ' 2' ' ' ARG . . . -60.62 -43.14 99.31 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.638 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.827 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 20' ' ' CYS . 22.5 pt-20 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.874 0.368 . . . . 0.0 110.552 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.582 179.949 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 1.6 p . . . . . 0 N--CA 1.457 -0.08 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.621 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.849 -1.072 . . . . 0.0 110.564 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -63.86 -42.0 97.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.959 0.409 . . . . 0.0 110.825 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.535 ' CG2' ' HA ' ' A' ' 7' ' ' PRO . 41.0 mm -61.18 -23.93 31.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.482 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 98.1 m-20 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.317 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.402 ' C ' ' H ' ' A' ' 8' ' ' ALA . 9.0 p . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.968 0.413 . . . . 0.0 110.577 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.535 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 53.2 Cg_endo -73.4 39.65 0.49 Allowed 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 122.77 2.313 . . . . 0.0 112.01 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.402 ' H ' ' C ' ' A' ' 6' ' ' CYS . . . -109.0 -31.74 7.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.47 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.72 158.85 31.89 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.439 ' HA2' ' CD1' ' A' ' 3' ' ' ILE . . . -62.87 -30.27 76.69 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.627 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.746 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.679 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 80.5 tt0 . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.779 0.323 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.4 179.916 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.679 ' SG ' ' N ' ' A' ' 14' ' ' GLU . 15.3 p . . . . . 0 CA--C 1.527 0.095 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.533 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -59.48 -34.69 72.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.949 0.404 . . . . 0.0 110.302 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.1 mm -63.02 -42.23 95.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.262 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 . . . . . 0 C--N 1.331 -0.214 0 CA-C-O 120.963 0.411 . . . . 0.0 110.572 -179.481 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.632 ' SG ' ' HD2' ' A' ' 7' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.134 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.634 ' O ' ' CB ' ' A' ' 8' ' ' ALA . 36.1 Cg_exo -56.96 -25.69 63.96 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.748 2.299 . . . . 0.0 111.92 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.634 ' CB ' ' O ' ' A' ' 7' ' ' PRO . . . 99.05 43.17 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.403 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.23 31.93 6.92 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.97 -63.16 2.04 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.458 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.5 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.608 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 97.4 mt-10 . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.936 0.398 . . . . 0.0 110.288 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.265 179.333 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' A' ' 14' ' ' GLU . 15.4 p . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.714 0.293 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.427 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.579 ' N ' ' OD1' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.536 ' HB3' ' CA ' ' A' ' 10' ' ' GLY . 90.3 mtm-85 -64.38 -37.96 89.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 110.68 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.6 ' O ' ' N ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -67.26 -23.15 29.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.552 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.579 ' OD1' ' N ' ' A' ' 1' ' ' GLY . 98.8 m-20 . . . . . 0 N--CA 1.462 0.151 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.09 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.667 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.112 0 CA-C-O 121.165 0.507 . . . . 0.0 110.341 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.476 ' HA ' ' HB ' ' A' ' 3' ' ' ILE . 58.5 Cg_endo -80.06 12.58 2.43 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 123.057 2.504 . . . . 0.0 112.03 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.2 -11.69 37.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.622 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 3' ' ' ILE . . . 172.14 170.41 35.99 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.536 ' CA ' ' HB3' ' A' ' 2' ' ' ARG . . . -64.02 -39.7 97.49 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.394 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.802 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 . . . . . 0 N--CA 1.456 -0.138 0 CA-C-O 120.944 0.402 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 . . . . . 0 C--N 1.331 -0.218 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.643 179.554 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 10.0 p . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.763 0.316 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.54 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.589 ' CG ' ' O ' ' A' ' 10' ' ' GLY . 0.6 OUTLIER -69.17 -22.92 63.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.881 0.372 . . . . 0.0 110.702 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.56 ' CG2' ' HA ' ' A' ' 7' ' ' PRO . 5.1 mm -105.99 3.24 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.446 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 67.4 t0 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.373 179.957 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.543 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 30.3 p . . . . . 0 CA--C 1.522 -0.123 0 CA-C-O 120.869 0.366 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.56 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 38.1 Cg_endo -69.88 23.41 0.18 Allowed 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.719 2.279 . . . . 0.0 111.961 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' A' ' 6' ' ' CYS . . . -89.13 -41.97 11.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.764 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.58 162.13 31.8 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.589 ' O ' ' CG ' ' A' ' 2' ' ' ARG . . . -64.03 -32.4 84.05 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.57 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -179.568 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.839 0.352 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.584 179.861 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 10.4 p . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.771 0.32 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.653 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.543 ' O ' ' CG ' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -61.44 -22.92 65.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.913 0.387 . . . . 0.0 110.57 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.564 ' O ' ' O ' ' A' ' 6' ' ' CYS . 90.5 mt -62.95 -42.79 97.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.495 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.543 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 51.1 p30 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.568 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.629 ' SG ' ' HD2' ' A' ' 7' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.102 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.629 ' HD2' ' SG ' ' A' ' 6' ' ' CYS . 32.8 Cg_exo -56.25 -23.47 45.83 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.862 2.375 . . . . 0.0 112.151 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.62 ' CB ' ' O ' ' A' ' 7' ' ' PRO . . . 94.45 44.22 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.469 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.68 33.12 6.48 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.55 -61.35 1.96 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.631 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.93 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.642 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 68.9 mm-40 . . . . . 0 N--CA 1.461 0.082 0 CA-C-O 120.907 0.384 . . . . 0.0 110.756 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.77 179.55 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.575 ' O ' ' C ' ' A' ' 20' ' ' CYS . 18.2 p . . . . . 0 CA--C 1.527 0.082 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.642 ' SG ' ' O ' ' A' ' 14' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.047 -0.978 . . . . 0.0 111.079 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -62.49 -43.56 98.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.784 0.326 . . . . 0.0 110.563 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.47 ' CG2' ' HA ' ' A' ' 7' ' ' PRO . 71.4 mt -81.31 -7.67 10.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.508 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 65.1 t0 . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.347 179.998 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.442 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 26.4 p . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 121.044 0.449 . . . . 0.0 110.418 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.47 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 42.0 Cg_endo -70.82 42.44 0.41 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.823 2.349 . . . . 0.0 111.961 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -114.99 -29.15 6.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.584 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.64 158.62 31.65 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.461 ' HA2' HD12 ' A' ' 3' ' ' ILE . . . -64.99 -31.21 80.18 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.622 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.744 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 58.3 mp0 . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.848 0.356 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.465 179.92 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 12.2 p . . . . . 0 N--CA 1.457 -0.075 0 CA-C-O 120.617 0.246 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.568 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.606 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -63.88 -38.78 92.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.786 0.327 . . . . 0.0 110.633 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 95.9 mt -66.21 -24.62 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.544 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 63.7 t0 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.532 179.9 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.634 ' SG ' ' HD2' ' A' ' 7' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.88 0.371 . . . . 0.0 110.537 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.639 ' O ' ' CB ' ' A' ' 8' ' ' ALA . 32.6 Cg_exo -57.51 -26.29 71.01 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.929 2.419 . . . . 0.0 111.975 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.639 ' CB ' ' O ' ' A' ' 7' ' ' PRO . . . 102.33 55.92 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.665 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -115.06 24.96 10.32 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.63 -59.08 1.66 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.477 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 179.587 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.665 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 17.7 pt-20 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.904 0.383 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.497 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 80.9 mt-30 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.565 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.665 ' SG ' ' N ' ' A' ' 14' ' ' GLU . 13.5 p . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.937 0.399 . . . . 0.0 110.738 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.846 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.371 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.507 ' O ' ' HB ' ' A' ' 3' ' ' ILE . 90.3 mtm-85 -67.42 146.9 53.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.804 0.335 . . . . 0.0 110.424 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 6' ' ' CYS . 43.3 mm 73.06 -16.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.638 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 2' ' ' ARG . 43.9 t0 . . . . . 0 C--N 1.332 -0.173 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.39 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.691 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.072 0 CA-C-O 121.24 0.543 . . . . 0.0 110.404 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -73.73 -9.17 22.32 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.8 2.334 . . . . 0.0 111.325 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.97 -38.21 90.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.436 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.409 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . -174.41 157.06 24.39 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.717 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.99 -23.81 40.25 Favored Glycine 0 C--N 1.331 0.303 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.394 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 178.697 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 120.777 0.322 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.479 -179.951 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 1.7 p . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.458 0.17 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.402 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--O 1.221 -0.423 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.441 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.533 ' O ' ' HB2' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.417 ' O ' ' CD1' ' A' ' 3' ' ' ILE . 90.5 mtm-85 -70.1 146.17 51.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 0.0 110.67 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.459 ' CG2' ' HA ' ' A' ' 7' ' ' PRO . 1.2 mp 73.01 -5.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.593 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 55.1 m-20 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.35 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.409 ' C ' ' H ' ' A' ' 8' ' ' ALA . 7.8 t . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.754 0.311 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.459 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 39.4 Cg_endo -69.46 6.89 1.04 Allowed 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.753 2.302 . . . . 0.0 112.109 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.409 ' H ' ' C ' ' A' ' 6' ' ' CYS . . . -64.39 -37.89 89.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.587 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.0 -171.47 43.43 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.16 160.79 26.4 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.654 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 -179.532 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.655 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 47.6 mt-10 . . . . . 0 N--CA 1.461 0.103 0 CA-C-O 120.878 0.371 . . . . 0.0 110.499 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.305 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.644 ' SG ' ' O ' ' A' ' 19' ' ' CYS . 9.7 p . . . . . 0 N--CA 1.463 0.178 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.655 ' SG ' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.561 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -61.88 -43.07 99.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.768 0.318 . . . . 0.0 110.611 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.548 HD13 ' N ' ' A' ' 4' ' ' ASP . 0.1 OUTLIER -72.26 -14.73 17.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.344 -179.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.548 ' N ' HD13 ' A' ' 3' ' ' ILE . 4.6 t0 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.416 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.521 ' O ' ' HB ' ' A' ' 3' ' ' ILE . 1.4 p . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.897 0.38 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.472 ' HA ' ' HB ' ' A' ' 3' ' ' ILE . 39.1 Cg_endo -69.98 18.25 0.2 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.936 2.424 . . . . 0.0 112.149 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.481 ' H ' ' C ' ' A' ' 6' ' ' CYS . . . -107.92 -74.09 0.67 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.755 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.562 ' O ' ' C ' ' A' ' 10' ' ' GLY . . . -176.13 172.66 45.65 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.562 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . -27.41 -52.93 0.09 OUTLIER Glycine 0 CA--C 1.518 0.239 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.531 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.68 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 120.644 0.259 . . . . 0.0 110.714 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.785 -179.999 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.619 ' SG ' ' O ' ' A' ' 19' ' ' CYS . 3.0 p . . . . . 0 CA--C 1.531 0.246 0 CA-C-O 120.591 0.234 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.221 -0.413 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.835 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 89.2 mtm-85 -61.13 -41.6 97.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.748 0.309 . . . . 0.0 110.563 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.609 ' O ' ' CD1' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -94.21 -5.22 10.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.458 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 67.2 t0 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.498 -179.593 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.658 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.814 0.34 . . . . 0.0 110.404 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.13 43.36 1.52 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.761 2.307 . . . . 0.0 112.19 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -121.01 -34.83 3.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.526 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.84 -178.7 47.57 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.48 -40.8 99.19 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.57 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.934 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 . . . . . 0 N--CA 1.455 -0.197 0 CA-C-O 120.799 0.333 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 179.775 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.597 ' O ' ' C ' ' A' ' 20' ' ' CYS . 17.5 p . . . . . 0 N--CA 1.456 -0.131 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.597 ' C ' ' O ' ' A' ' 19' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 117.97 -1.015 . . . . 0.0 110.681 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.527 ' HG3' ' CA ' ' A' ' 10' ' ' GLY . 23.8 tpt180 -61.96 -42.78 99.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.294 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.43 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -75.37 -15.32 15.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.846 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 3' ' ' ILE . 68.2 t0 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.832 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.654 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 121.185 0.517 . . . . 0.0 109.921 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -84.02 42.94 1.29 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 123.117 2.544 . . . . 0.0 112.381 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.504 ' HB3' ' OE1' ' A' ' 15' ' ' GLN . . . -126.7 -33.06 2.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.681 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.35 172.2 45.01 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.527 ' CA ' ' HG3' ' A' ' 2' ' ' ARG . . . -64.93 -38.32 95.36 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.461 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . . . . . . 0 CA--C 1.523 0.537 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.732 0.301 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.504 ' OE1' ' HB3' ' A' ' 8' ' ' ALA . 79.6 mt-30 . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.553 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.148 0 CA-C-O 120.979 0.419 . . . . 0.0 109.908 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.639 179.874 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.424 ' HA3' ' CB ' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.493 2.449 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -59.3 -42.79 92.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.981 0.42 . . . . 0.0 110.162 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.533 ' O ' ' O ' ' A' ' 6' ' ' CYS . 5.7 pt -102.07 -0.44 10.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.967 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.424 ' CB ' ' HA3' ' A' ' 1' ' ' GLY . 65.1 t0 . . . . . 0 C--N 1.333 -0.147 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.021 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.596 ' SG ' ' HD2' ' A' ' 7' ' ' PRO . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 120.909 0.385 . . . . 0.0 110.255 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.626 ' O ' ' CB ' ' A' ' 8' ' ' ALA . 31.7 Cg_exo -57.56 -25.74 68.67 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 123.147 2.565 . . . . 0.0 112.239 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.626 ' CB ' ' O ' ' A' ' 7' ' ' PRO . . . 100.05 46.85 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.902 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.98 20.9 48.98 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.79 -58.1 3.86 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.168 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 178.719 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.641 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 49.8 tp10 . . . . . 0 N--CA 1.455 -0.207 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.496 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 48.2 mt-30 . . . . . 0 N--CA 1.455 -0.194 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.402 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.552 ' SG ' ' N ' ' A' ' 14' ' ' GLU . 9.6 p . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.896 0.379 . . . . 0.0 110.522 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.641 ' SG ' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.497 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -64.01 -37.57 87.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.752 0.31 . . . . 0.0 110.463 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.574 HG13 ' N ' ' A' ' 6' ' ' CYS . 0.7 OUTLIER -100.04 1.54 10.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.09 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 3' ' ' ILE . 99.0 m-20 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.391 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.643 ' SG ' ' O ' ' A' ' 9' ' ' GLY . 1.6 p . . . . . 0 CA--C 1.529 0.146 0 CA-C-O 120.907 0.384 . . . . 0.0 110.017 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.425 ' HA ' ' HB ' ' A' ' 3' ' ' ILE . 45.9 Cg_endo -69.69 54.72 1.18 Allowed 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 123.217 2.612 . . . . 0.0 113.332 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.572 ' CB ' ' HB3' ' A' ' 15' ' ' GLN . . . -158.41 -36.81 0.07 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.8 0.333 . . . . 0.0 110.496 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.643 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . 158.71 -168.23 34.86 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.46 170.55 26.8 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.595 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . . . . . . 0 CA--C 1.52 0.348 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 . . . . . 0 CA--C 1.522 -0.104 0 CA-C-O 120.981 0.42 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.572 ' HB3' ' CB ' ' A' ' 8' ' ' ALA . 77.8 mt-30 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.826 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.595 ' SG ' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.8 0.333 . . . . 0.0 110.237 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 19' ' ' CYS . 1.5 m . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.632 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -63.37 -41.02 98.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 110.701 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.3 mm -77.17 -0.98 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.501 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 45.6 t0 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.539 -179.656 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.59 ' SG ' ' HD2' ' A' ' 7' ' ' PRO . 4.9 t . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.936 0.398 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.611 ' O ' ' CB ' ' A' ' 8' ' ' ALA . 52.6 Cg_exo -51.63 -8.57 0.28 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.874 2.382 . . . . 0.0 112.181 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.611 ' CB ' ' O ' ' A' ' 7' ' ' PRO . . . 91.37 28.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.496 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.64 16.79 55.61 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.27 -54.99 1.52 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.498 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.566 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.557 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 58.1 mp0 . . . . . 0 N--CA 1.455 -0.201 0 CA-C-O 120.856 0.36 . . . . 0.0 110.705 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.536 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 92.3 mm-40 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.044 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.641 ' SG ' ' O ' ' A' ' 19' ' ' CYS . 0.8 OUTLIER . . . . . 0 CA--C 1.519 -0.222 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.647 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.218 -0.556 0 CA-C-O 117.91 -1.043 . . . . 0.0 110.787 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.556 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 80.3 mtp85 -67.27 145.34 55.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.813 0.339 . . . . 0.0 110.572 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.578 ' HA ' ' O ' ' A' ' 6' ' ' CYS . 30.5 mm 73.4 -16.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.561 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.502 ' H ' ' C ' ' A' ' 2' ' ' ARG . 67.3 t0 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.568 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.687 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.857 0.36 . . . . 0.0 110.488 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.99 -2.83 13.1 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.846 2.364 . . . . 0.0 112.14 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.02 -39.69 72.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.578 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.514 ' O ' HD13 ' A' ' 3' ' ' ILE . . . -165.59 165.04 37.7 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.556 ' O ' ' CB ' ' A' ' 2' ' ' ARG . . . -63.54 -35.04 91.51 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.662 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.775 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.446 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 59.8 mp0 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.823 0.344 . . . . 0.0 110.581 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.606 179.957 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.409 0.147 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.221 -0.423 0 CA-C-O 117.865 -1.064 . . . . 0.0 110.466 -179.985 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -62.58 -43.19 99.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.825 0.345 . . . . 0.0 110.615 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.527 ' CG1' ' HA2' ' A' ' 10' ' ' GLY . 6.1 mt -57.44 -16.2 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.428 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 65.2 t0 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.283 -179.808 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.687 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 121.053 0.454 . . . . 0.0 110.092 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.91 14.99 1.38 Allowed 'Trans proline' 0 C--N 1.304 -1.816 0 C-N-CA 122.855 2.37 . . . . 0.0 112.014 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.63 -51.94 6.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.616 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.5 ' C ' HG12 ' A' ' 3' ' ' ILE . . . 172.1 168.72 33.96 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.527 ' HA2' ' CG1' ' A' ' 3' ' ' ILE . . . -41.78 -23.51 0.13 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . 0 CA--C 1.52 0.393 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 120.808 0.337 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.566 179.926 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 18.8 p . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.646 0.26 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.617 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--O 1.219 -0.526 0 CA-C-O 117.924 -1.036 . . . . 0.0 110.612 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.596 ' NH2' ' O ' ' A' ' 10' ' ' GLY . 79.6 mtp85 -62.57 140.07 58.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.809 0.338 . . . . 0.0 110.543 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.559 ' HB ' ' O ' ' A' ' 2' ' ' ARG . 50.6 mm 73.38 -27.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.534 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.538 ' H ' ' C ' ' A' ' 2' ' ' ARG . 56.4 m-20 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.568 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.695 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 121.115 0.483 . . . . 0.0 110.217 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -75.39 -8.48 19.65 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.845 2.364 . . . . 0.0 112.093 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.01 -38.73 91.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.579 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.16 163.52 36.88 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.596 ' O ' ' NH2' ' A' ' 2' ' ' ARG . . . -63.32 -33.7 87.97 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.76 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.894 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.464 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 56.5 mp0 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.81 0.338 . . . . 0.0 110.604 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.541 -179.951 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.8 p . . . . . 0 CA--C 1.532 0.271 0 N-CA-C 110.853 -0.055 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.622 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.512 ' O ' ' HB2' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.531 ' O ' ' HG2' ' A' ' 18' ' ' DBU . 28.4 mmt85 -64.61 -41.5 96.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.833 0.349 . . . . 0.0 110.629 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.532 ' CG2' ' HA ' ' A' ' 7' ' ' PRO . 84.8 mt -72.29 -4.6 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.75 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 99.2 m-20 -62.12 -42.41 99.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.377 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.671 ' HB3' ' C ' ' A' ' 16' ' ' DBB . 9.5 p -140.51 82.6 15.98 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.857 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.532 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 49.1 Cg_endo -72.09 43.42 0.59 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.692 2.261 . . . . 0.0 111.878 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -114.11 -30.58 6.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.428 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.4 ' O ' HG12 ' A' ' 3' ' ' ILE . . . -167.86 161.1 34.87 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.507 ' HA2' ' CG1' ' A' ' 3' ' ' ILE . . . -64.69 -31.75 81.95 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -55.18 -44.46 83.96 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' DBB . . . . . 0.561 ' HA ' ' CG ' ' A' ' 18' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' DAL . . . . . 0.611 ' C ' ' N ' ' A' ' 15' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.625 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 78.9 mm-40 -41.63 -17.88 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.448 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.611 ' N ' ' C ' ' A' ' 13' ' ' DAL . 98.5 mm-40 -53.96 -8.92 0.21 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.896 0.379 . . . . 0.0 110.417 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' DBB . . . . . 0.671 ' C ' ' HB3' ' A' ' 6' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.66 ' O ' ' C ' ' A' ' 18' ' ' DBU . . . 10.79 -123.49 0.01 OUTLIER Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' DBU . . . . . 0.66 ' C ' ' O ' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.625 ' SG ' ' N ' ' A' ' 14' ' ' GLU . 12.6 p -103.76 -12.13 17.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.315 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.575 ' HB3' ' C ' ' A' ' 16' ' ' DBB . 0.1 OUTLIER . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.313 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.574 ' O ' ' OD1' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.493 ' HB3' ' CA ' ' A' ' 10' ' ' GLY . 84.3 mtp180 -61.95 -36.2 80.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.832 0.348 . . . . 0.0 110.594 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.585 HD11 ' N ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -52.7 -36.66 23.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.516 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.574 ' OD1' ' O ' ' A' ' 1' ' ' GLY . 90.1 m-20 32.15 56.19 0.35 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.629 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' DBU . . . . . 0.528 ' O ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.669 ' SG ' ' CG ' ' A' ' 18' ' ' DBU . 22.5 p -68.04 109.2 3.55 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.572 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 5' ' ' DBU . 56.9 Cg_endo -78.5 18.33 0.97 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.918 2.412 . . . . 0.0 112.175 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -85.92 -42.38 14.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.614 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.4 171.99 44.28 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.493 ' CA ' ' HB3' ' A' ' 2' ' ' ARG . . . -60.62 -43.14 99.31 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -43.16 -72.54 0.31 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' DBB . . . . . 0.571 ' O ' ' N ' ' A' ' 19' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' DAL . . . . . 0.612 ' C ' ' H ' ' A' ' 15' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 20' ' ' CYS . 22.5 pt-20 -53.51 -6.67 0.08 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.874 0.368 . . . . 0.0 110.552 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.612 ' H ' ' C ' ' A' ' 13' ' ' DAL . 76.4 mt-30 -54.97 -39.53 69.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.582 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' DBB . . . . . 0.641 ' O ' ' C ' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.749 ' O ' ' C ' ' A' ' 18' ' ' DBU . . . -10.35 -107.17 0.0 OUTLIER Glycine 0 CA--C 1.522 0.477 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' DBU . . . . . 0.749 ' C ' ' O ' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.616 ' N ' ' O ' ' A' ' 17' ' ' GLY . 1.6 p -118.95 -35.96 3.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.534 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.621 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.849 -1.072 . . . . 0.0 110.564 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.6 ' O ' ' CG ' ' A' ' 18' ' ' DBU . 99.4 mtt180 -63.86 -42.0 97.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.959 0.409 . . . . 0.0 110.825 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.535 ' CG2' ' HA ' ' A' ' 7' ' ' PRO . 41.0 mm -61.18 -23.93 31.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.482 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.581 ' O ' ' CG ' ' A' ' 5' ' ' DBU . 98.1 m-20 -57.74 81.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.317 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' DBU . . . . . 0.581 ' CG ' ' O ' ' A' ' 4' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.68 ' HB3' ' C ' ' A' ' 16' ' ' DBB . 9.0 p -128.99 83.54 65.88 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.577 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.535 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 53.2 Cg_endo -73.4 39.65 0.49 Allowed 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 122.77 2.313 . . . . 0.0 112.01 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.402 ' H ' ' C ' ' A' ' 6' ' ' CYS . . . -109.0 -31.74 7.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.47 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.72 158.85 31.89 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.439 ' HA2' ' CD1' ' A' ' 3' ' ' ILE . . . -62.87 -30.27 76.69 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.57 -44.36 93.89 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' DBB . . . . . 0.583 ' HA ' ' CG ' ' A' ' 18' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' DAL . . . . . 0.603 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.673 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 80.5 tt0 -39.3 -20.87 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.617 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.603 ' N ' ' O ' ' A' ' 13' ' ' DAL . 99.7 mm-40 -53.65 -9.57 0.22 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.4 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' DBB . . . . . 0.68 ' C ' ' HB3' ' A' ' 6' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.676 ' O ' ' C ' ' A' ' 18' ' ' DBU . . . 11.97 -126.44 0.01 OUTLIER Glycine 0 CA--C 1.521 0.429 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' DBU . . . . . 0.676 ' C ' ' O ' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.673 ' SG ' ' N ' ' A' ' 14' ' ' GLU . 15.3 p -96.54 -12.98 23.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.583 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.583 ' HB3' ' C ' ' A' ' 16' ' ' DBB . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.533 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.488 ' HB3' ' HG1' ' A' ' 18' ' ' DBU . 94.2 mtt-85 -59.48 -34.69 72.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.949 0.404 . . . . 0.0 110.302 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.1 mm -63.02 -42.23 95.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.262 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -59.56 140.31 56.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.963 0.411 . . . . 0.0 110.572 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' DBU . . . . . 0.628 ' C ' ' N ' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.686 ' SG ' ' C ' ' A' ' 16' ' ' DBB . 0.5 OUTLIER -97.34 155.6 37.18 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.187 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.634 ' O ' ' CB ' ' A' ' 8' ' ' ALA . 36.1 Cg_exo -56.96 -25.69 63.96 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.748 2.299 . . . . 0.0 111.92 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.634 ' CB ' ' O ' ' A' ' 7' ' ' PRO . . . 99.05 43.17 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.403 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.23 31.93 6.92 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.97 -63.16 2.04 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.469 ' C ' ' N ' ' A' ' 13' ' ' DAL . . . -63.26 -39.38 97.8 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' DBB . . . . . 0.553 ' HA ' ' CG ' ' A' ' 18' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' DAL . . . . . 0.601 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.608 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 97.4 mt-10 -39.64 -20.55 0.01 OUTLIER 'General case' 0 C--N 1.341 0.233 0 CA-C-O 120.936 0.398 . . . . 0.0 110.288 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.601 ' N ' ' O ' ' A' ' 13' ' ' DAL . 84.1 mt-30 -54.52 -8.92 0.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.265 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' DBB . . . . . 0.686 ' C ' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.635 ' O ' ' C ' ' A' ' 18' ' ' DBU . . . 9.57 -118.45 0.01 OUTLIER Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' DBU . . . . . 0.635 ' C ' ' O ' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' A' ' 14' ' ' GLU . 15.4 p -116.19 -10.55 11.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.978 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.594 ' N ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.427 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.579 ' N ' ' OD1' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.536 ' HB3' ' CA ' ' A' ' 10' ' ' GLY . 90.3 mtm-85 -64.38 -37.96 89.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 110.68 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.6 ' O ' ' N ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -67.26 -23.15 29.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.552 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.595 ' O ' ' CG ' ' A' ' 18' ' ' DBU . 98.8 m-20 -21.75 113.49 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.09 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' DBU . . . . . 0.61 ' C ' ' HA3' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.667 ' SG ' ' O ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -104.25 96.97 10.67 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.341 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 5' ' ' DBU . 58.5 Cg_endo -80.06 12.58 2.43 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 123.057 2.504 . . . . 0.0 112.03 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.2 -11.69 37.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.622 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 3' ' ' ILE . . . 172.14 170.41 35.99 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.536 ' CA ' ' HB3' ' A' ' 2' ' ' ARG . . . -64.02 -39.7 97.49 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.7 -76.09 0.27 Allowed Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' DBB . . . . . 0.673 ' CG ' ' N ' ' A' ' 16' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' DAL . . . . . 0.517 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -72.86 -4.05 29.38 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 120.499 -0.48 . . . . 0.0 109.973 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.575 ' C ' ' CG ' ' A' ' 12' ' ' DBB . 89.2 mt-30 -71.15 -6.96 43.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.643 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' DBB . . . . . 0.673 ' N ' ' CG ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.613 ' O ' ' CB ' ' A' ' 6' ' ' CYS . . . -32.7 162.24 0.0 OUTLIER Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.762 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' DBU . . . . . 0.595 ' CG ' ' O ' ' A' ' 4' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' A' ' 13' ' ' DAL . 10.0 p -136.97 3.63 2.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.728 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.673 ' HB2' ' C ' ' A' ' 16' ' ' DBB . 0.8 OUTLIER . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.54 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.476 ' O ' ' HG2' ' A' ' 18' ' ' DBU . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.589 ' CG ' ' O ' ' A' ' 10' ' ' GLY . 0.6 OUTLIER -69.17 -22.92 63.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.881 0.372 . . . . 0.0 110.702 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.56 ' CG2' ' HA ' ' A' ' 7' ' ' PRO . 5.1 mm -105.99 3.24 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.446 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -85.09 106.65 16.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.373 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' DBU . . . . . 0.496 ' C ' ' HA3' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.648 ' SG ' ' O ' ' A' ' 17' ' ' GLY . 30.3 p -150.86 78.65 7.33 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.916 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.56 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 38.1 Cg_endo -69.88 23.41 0.18 Allowed 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.719 2.279 . . . . 0.0 111.961 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' A' ' 6' ' ' CYS . . . -89.13 -41.97 11.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.764 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.58 162.13 31.8 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.589 ' O ' ' CG ' ' A' ' 2' ' ' ARG . . . -64.03 -32.4 84.05 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -53.7 -43.37 69.08 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' DBB . . . . . 0.618 ' HG3' ' C ' ' A' ' 16' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' DAL . . . . . 0.518 ' HB1' ' O ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.479 ' C ' ' H ' ' A' ' 16' ' ' DBB . 45.0 mt-10 -59.19 -17.12 24.76 Favored 'General case' 0 C--O 1.232 0.165 0 O-C-N 122.054 -0.404 . . . . 0.0 110.581 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.492 ' HB2' ' CG ' ' A' ' 12' ' ' DBB . 84.6 mt-30 -57.14 -6.57 0.4 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.584 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' DBB . . . . . 0.618 ' C ' ' HG3' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.648 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . -28.04 149.6 0.01 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' DBU . . . . . 0.572 ' CG ' ' O ' ' A' ' 2' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 10.4 p -133.73 -20.84 1.99 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.06 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 16' ' ' DBB . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.653 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.543 ' O ' ' CG ' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.525 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 95.0 mtt180 -61.44 -22.92 65.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.913 0.387 . . . . 0.0 110.57 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.564 ' O ' ' O ' ' A' ' 6' ' ' CYS . 90.5 mt -62.95 -42.79 97.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.495 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 5' ' ' DBU . 51.1 p30 -43.8 -20.85 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.568 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' DBU . . . . . 0.591 ' C ' ' H ' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.692 ' SG ' ' C ' ' A' ' 16' ' ' DBB . 0.5 OUTLIER -86.69 154.25 55.87 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.102 179.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.629 ' HD2' ' SG ' ' A' ' 6' ' ' CYS . 32.8 Cg_exo -56.25 -23.47 45.83 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.862 2.375 . . . . 0.0 112.151 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.62 ' CB ' ' O ' ' A' ' 7' ' ' PRO . . . 94.45 44.22 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.469 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.68 33.12 6.48 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.55 -61.35 1.96 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.406 ' C ' ' N ' ' A' ' 13' ' ' DAL . . . -64.42 -38.74 96.2 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' DBB . . . . . 0.564 ' HA ' ' CG ' ' A' ' 18' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' DAL . . . . . 0.603 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.642 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 68.9 mm-40 -38.57 -21.36 0.01 OUTLIER 'General case' 0 C--N 1.34 0.181 0 CA-C-O 120.907 0.384 . . . . 0.0 110.756 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.603 ' N ' ' O ' ' A' ' 13' ' ' DAL . 40.7 mt-30 -50.94 -24.61 3.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.77 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' DBB . . . . . 0.709 ' C ' ' HB2' ' A' ' 20' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.664 ' O ' ' C ' ' A' ' 18' ' ' DBU . . . 6.56 -119.69 0.01 OUTLIER Glycine 0 N--CA 1.463 0.486 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' DBU . . . . . 0.664 ' C ' ' O ' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.575 ' O ' ' C ' ' A' ' 20' ' ' CYS . 18.2 p -105.33 -21.41 13.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.186 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.709 ' HB2' ' C ' ' A' ' 16' ' ' DBB . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.047 -0.978 . . . . 0.0 111.079 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.558 ' HB3' ' CG ' ' A' ' 18' ' ' DBU . 83.8 mtt85 -62.49 -43.56 98.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.784 0.326 . . . . 0.0 110.563 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.47 ' CG2' ' HA ' ' A' ' 7' ' ' PRO . 71.4 mt -81.31 -7.67 10.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.508 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -61.75 -42.65 99.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.347 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.67 ' SG ' ' O ' ' A' ' 17' ' ' GLY . 26.4 p -125.71 78.16 69.22 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.418 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.47 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 42.0 Cg_endo -70.82 42.44 0.41 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.823 2.349 . . . . 0.0 111.961 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -114.99 -29.15 6.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.584 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.64 158.62 31.65 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.461 ' HA2' HD12 ' A' ' 3' ' ' ILE . . . -64.99 -31.21 80.18 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -54.7 -42.82 79.02 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' DBB . . . . . 0.614 ' HG3' ' C ' ' A' ' 16' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' DAL . . . . . 0.477 ' HB1' ' O ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.499 ' C ' ' H ' ' A' ' 16' ' ' DBB . 58.3 mp0 -60.64 -16.52 39.55 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.848 0.356 . . . . 0.0 110.494 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.497 ' HB2' ' CG ' ' A' ' 12' ' ' DBB . 85.3 mt-30 -58.79 -4.12 0.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.465 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' DBB . . . . . 0.614 ' C ' ' HG3' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.67 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . -28.15 148.53 0.01 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' DBU . . . . . 0.558 ' CG ' ' HB3' ' A' ' 2' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 12.2 p -135.1 -10.75 2.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.944 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.568 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.606 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.48 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 83.4 mtp180 -63.88 -38.78 92.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.786 0.327 . . . . 0.0 110.633 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 95.9 mt -66.21 -24.62 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.544 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -62.71 -41.48 99.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.532 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.746 ' SG ' ' C ' ' A' ' 16' ' ' DBB . 0.1 OUTLIER -75.95 158.73 82.07 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.537 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.639 ' O ' ' CB ' ' A' ' 8' ' ' ALA . 32.6 Cg_exo -57.51 -26.29 71.01 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.929 2.419 . . . . 0.0 111.975 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.639 ' CB ' ' O ' ' A' ' 7' ' ' PRO . . . 102.33 55.92 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.665 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -115.06 24.96 10.32 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.63 -59.08 1.66 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 13' ' ' DAL . . . -62.77 -33.95 88.33 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' DBB . . . . . 0.623 ' O ' ' O ' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' DAL . . . . . 0.614 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.665 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 17.7 pt-20 -37.65 -22.97 0.01 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.904 0.383 . . . . 0.0 110.257 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.614 ' N ' ' O ' ' A' ' 13' ' ' DAL . 80.9 mt-30 -54.65 -7.9 0.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.565 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' DBB . . . . . 0.746 ' C ' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.623 ' O ' ' O ' ' A' ' 12' ' ' DBB . . . -35.83 132.53 0.72 Allowed Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.665 ' SG ' ' N ' ' A' ' 14' ' ' GLU . 13.5 p -140.8 8.56 2.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.738 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.51 ' HB3' ' O ' ' A' ' 16' ' ' DBB . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.846 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.371 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.507 ' O ' ' HB ' ' A' ' 3' ' ' ILE . 90.3 mtm-85 -67.42 146.9 53.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.804 0.335 . . . . 0.0 110.424 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 6' ' ' CYS . 43.3 mm 73.06 -16.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.638 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 2' ' ' ARG . 43.9 t0 -63.52 -40.56 97.37 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.39 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' DBU . . . . . 0.606 ' C ' ' HA3' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.691 ' SG ' ' O ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -111.12 88.38 8.41 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.404 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -73.73 -9.17 22.32 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.8 2.334 . . . . 0.0 111.325 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.97 -38.21 90.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.436 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.409 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . -174.41 157.06 24.39 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.717 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.99 -23.81 40.25 Favored Glycine 0 C--N 1.331 0.303 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 13' ' ' DAL . . . -87.22 51.74 4.27 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' DBB . . . . . 0.66 ' CG ' ' N ' ' A' ' 16' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' DAL . . . . . 0.535 ' HB1' ' O ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -75.0 -5.03 41.79 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.405 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.556 ' HB2' ' CG ' ' A' ' 12' ' ' DBB . 86.3 mt-30 -72.86 -8.04 53.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.479 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' DBB . . . . . 0.66 ' N ' ' CG ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.606 ' HA3' ' C ' ' A' ' 5' ' ' DBU . . . -31.68 156.71 0.0 OUTLIER Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 1.7 p -156.65 -31.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.039 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 13' ' ' DAL . 0.5 OUTLIER . . . . . 0 C--O 1.221 -0.423 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.441 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.533 ' O ' ' HB2' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.417 ' CB ' HD12 ' A' ' 3' ' ' ILE . 90.5 mtm-85 -70.1 146.17 51.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 0.0 110.67 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.459 ' CG2' ' HA ' ' A' ' 7' ' ' PRO . 1.2 mp 73.01 -5.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.593 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 55.1 m-20 -61.71 -39.87 93.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.35 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' DBU . . . . . 0.594 ' C ' ' H ' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.682 ' SG ' ' N ' ' A' ' 16' ' ' DBB . 7.8 t -117.92 57.89 2.71 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.273 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.527 ' HD3' ' C ' ' A' ' 5' ' ' DBU . 39.4 Cg_endo -69.46 6.89 1.04 Allowed 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.753 2.302 . . . . 0.0 112.109 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.409 ' H ' ' C ' ' A' ' 6' ' ' CYS . . . -64.39 -37.89 89.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.587 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.0 -171.47 43.43 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.49 ' C ' ' H ' ' A' ' 12' ' ' DBB . . . -61.16 160.79 26.4 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.613 ' O ' ' N ' ' A' ' 13' ' ' DAL . . . 75.55 -25.69 1.38 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' DBB . . . . . 0.587 ' HA ' ' CG ' ' A' ' 18' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' DAL . . . . . 0.614 ' C ' ' H ' ' A' ' 15' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.655 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 47.6 mt-10 -43.74 -15.42 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.103 0 CA-C-O 120.878 0.371 . . . . 0.0 110.499 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.614 ' H ' ' C ' ' A' ' 13' ' ' DAL . 0.4 OUTLIER -54.4 -33.82 60.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.305 179.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' DBB . . . . . 0.703 ' C ' ' HB2' ' A' ' 20' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.79 ' O ' ' C ' ' A' ' 18' ' ' DBU . . . -16.29 -99.23 0.01 OUTLIER Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.039 -0.825 . . . . 0.0 111.039 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' DBU . . . . . 0.79 ' C ' ' O ' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.644 ' SG ' ' O ' ' A' ' 19' ' ' CYS . 9.7 p -139.16 50.99 1.8 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.658 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.703 ' HB2' ' C ' ' A' ' 16' ' ' DBB . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.561 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -61.88 -43.07 99.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.768 0.318 . . . . 0.0 110.611 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.548 HD13 ' N ' ' A' ' 4' ' ' ASP . 0.1 OUTLIER -72.26 -14.73 17.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.344 -179.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.584 ' O ' ' CG ' ' A' ' 18' ' ' DBU . 4.6 t0 66.47 43.56 2.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.416 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' DBU . . . . . 0.452 ' H ' ' CD1' ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.521 ' O ' ' HB ' ' A' ' 3' ' ' ILE . 1.4 p -100.83 140.61 21.48 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.403 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.472 ' HA ' ' HB ' ' A' ' 3' ' ' ILE . 39.1 Cg_endo -69.98 18.25 0.2 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.936 2.424 . . . . 0.0 112.149 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.481 ' H ' ' C ' ' A' ' 6' ' ' CYS . . . -107.92 -74.09 0.67 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.755 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.562 ' O ' ' C ' ' A' ' 10' ' ' GLY . . . -176.13 172.66 45.65 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.562 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . -27.41 -52.93 0.09 OUTLIER Glycine 0 CA--C 1.518 0.239 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.669 ' C ' ' H ' ' A' ' 13' ' ' DAL . . . -73.78 55.96 2.15 Favored Glycine 0 CA--C 1.523 0.531 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' DBB . . . . . 0.667 ' CG ' ' N ' ' A' ' 16' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' DAL . . . . . 0.669 ' H ' ' C ' ' A' ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -72.0 -1.86 16.12 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.714 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.532 ' HB2' ' CG ' ' A' ' 12' ' ' DBB . 98.2 mm-40 -70.11 -10.51 59.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.785 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' DBB . . . . . 0.715 ' C ' ' HB2' ' A' ' 20' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.713 ' O ' ' C ' ' A' ' 18' ' ' DBU . . . -6.2 -109.15 0.0 OUTLIER Glycine 0 N--CA 1.466 0.655 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' DBU . . . . . 0.713 ' C ' ' O ' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.619 ' SG ' ' O ' ' A' ' 19' ' ' CYS . 3.0 p -132.89 40.0 3.27 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.184 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.715 ' HB2' ' C ' ' A' ' 16' ' ' DBB . 0.1 OUTLIER . . . . . 0 C--O 1.221 -0.413 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.835 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.538 ' O ' ' HG1' ' A' ' 18' ' ' DBU . 89.2 mtm-85 -61.13 -41.6 97.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.748 0.309 . . . . 0.0 110.563 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.609 ' O ' ' CD1' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -94.21 -5.22 10.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.458 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -60.35 -43.99 95.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.498 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' DBU . . . . . 0.583 ' C ' ' H ' ' A' ' 18' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.658 ' SG ' ' O ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -118.01 122.45 30.46 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.404 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.13 43.36 1.52 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.761 2.307 . . . . 0.0 112.19 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -121.01 -34.83 3.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.526 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.84 -178.7 47.57 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.48 -40.8 99.19 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.61 -73.97 0.42 Allowed Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' DBB . . . . . 0.644 ' HG3' ' O ' ' A' ' 16' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' DAL . . . . . 0.506 ' HB1' ' O ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -69.13 -5.72 24.06 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.799 0.333 . . . . 0.0 110.398 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.594 ' HB2' ' CG ' ' A' ' 12' ' ' DBB . 79.5 mt-30 -61.77 -28.09 69.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' DBB . . . . . 0.715 ' C ' ' HB2' ' A' ' 20' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.676 ' O ' ' C ' ' A' ' 18' ' ' DBU . . . -3.03 -115.42 0.0 OUTLIER Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' DBU . . . . . 0.676 ' C ' ' O ' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.597 ' O ' ' C ' ' A' ' 20' ' ' CYS . 17.5 p -106.52 -29.68 9.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.709 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.715 ' HB2' ' C ' ' A' ' 16' ' ' DBB . 0.8 OUTLIER . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 117.97 -1.015 . . . . 0.0 110.681 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.527 ' HG3' ' CA ' ' A' ' 10' ' ' GLY . 23.8 tpt180 -61.96 -42.78 99.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.294 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.43 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -75.37 -15.32 15.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.846 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.585 ' O ' ' CG ' ' A' ' 18' ' ' DBU . 68.2 t0 -38.81 123.72 1.3 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.832 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' DBU . . . . . 0.582 ' C ' ' HA3' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.654 ' SG ' ' O ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -117.25 104.07 50.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.921 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -84.02 42.94 1.29 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 123.117 2.544 . . . . 0.0 112.381 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.504 ' HB3' ' OE1' ' A' ' 15' ' ' GLN . . . -126.7 -33.06 2.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.681 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.35 172.2 45.01 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.527 ' CA ' ' HG3' ' A' ' 2' ' ' ARG . . . -64.93 -38.32 95.36 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.461 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -61.22 -45.21 96.96 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' DBB . . . . . 0.637 ' HG2' ' C ' ' A' ' 16' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' DAL . . . . . 0.607 ' HB2' ' O ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -78.39 27.55 0.2 Allowed 'General case' 0 C--O 1.231 0.116 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.472 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.6 ' C ' ' CG ' ' A' ' 12' ' ' DBB . 79.6 mt-30 -132.97 -3.77 3.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.553 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' DBB . . . . . 0.67 ' O ' ' O ' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.67 ' O ' ' O ' ' A' ' 16' ' ' DBB . . . -24.96 160.15 0.0 OUTLIER Glycine 0 CA--C 1.526 0.743 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.859 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' DBU . . . . . 0.585 ' CG ' ' O ' ' A' ' 4' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.62 ' SG ' ' C ' ' A' ' 12' ' ' DBB . 0.1 OUTLIER -98.7 -27.25 14.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 111.422 -2.626 . . . . 0.0 109.908 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.612 ' HB2' ' C ' ' A' ' 16' ' ' DBB . 1.5 m . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.639 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.424 ' HA3' ' CB ' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.493 2.449 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.517 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 16.5 ttm180 -59.3 -42.79 92.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.981 0.42 . . . . 0.0 110.162 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.533 ' O ' ' O ' ' A' ' 6' ' ' CYS . 5.7 pt -102.07 -0.44 10.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.967 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.424 ' CB ' ' HA3' ' A' ' 1' ' ' GLY . 65.1 t0 -63.02 -43.34 99.01 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.021 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.596 ' SG ' ' HD2' ' A' ' 7' ' ' PRO . 0.3 OUTLIER -78.76 155.11 78.33 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.255 179.794 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.626 ' O ' ' CB ' ' A' ' 8' ' ' ALA . 31.7 Cg_exo -57.56 -25.74 68.67 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 123.147 2.565 . . . . 0.0 112.239 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.626 ' CB ' ' O ' ' A' ' 7' ' ' PRO . . . 100.05 46.85 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.902 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.98 20.9 48.98 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.79 -58.1 3.86 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.535 ' O ' ' C ' ' A' ' 12' ' ' DBB . . . -65.31 -33.69 87.4 Favored Glycine 0 CA--C 1.517 0.168 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' DBB . . . . . 0.583 ' O ' ' O ' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' DAL . . . . . 0.644 ' C ' ' N ' ' A' ' 15' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.641 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 49.8 tp10 -41.0 -21.44 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.644 ' N ' ' C ' ' A' ' 13' ' ' DAL . 48.2 mt-30 -52.25 -9.74 0.11 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.402 178.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' DBB . . . . . 0.637 ' C ' ' HB2' ' A' ' 20' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.583 ' O ' ' O ' ' A' ' 12' ' ' DBB . . . -24.37 142.19 0.01 OUTLIER Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' DBU . . . . . 0.449 ' CG ' ' HG2' ' A' ' 2' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.552 ' SG ' ' N ' ' A' ' 14' ' ' GLU . 9.6 p -120.49 -7.12 9.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.522 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.641 ' SG ' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.497 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -64.01 -37.57 87.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.752 0.31 . . . . 0.0 110.463 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.574 HG13 ' N ' ' A' ' 6' ' ' CYS . 0.7 OUTLIER -100.04 1.54 10.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.09 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.581 ' O ' ' CG ' ' A' ' 18' ' ' DBU . 99.0 m-20 63.42 34.08 13.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.391 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' DBU . . . . . 0.645 ' C ' ' HG2' ' A' ' 18' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.643 ' SG ' ' O ' ' A' ' 9' ' ' GLY . 1.6 p -114.01 134.35 22.17 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.017 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.425 ' HA ' ' HB ' ' A' ' 3' ' ' ILE . 45.9 Cg_endo -69.69 54.72 1.18 Allowed 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 123.217 2.612 . . . . 0.0 113.332 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.572 ' CB ' ' HB3' ' A' ' 15' ' ' GLN . . . -158.41 -36.81 0.07 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.8 0.333 . . . . 0.0 110.496 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.643 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . 158.71 -168.23 34.86 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.486 ' C ' ' H ' ' A' ' 12' ' ' DBB . . . -65.46 170.55 26.8 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.595 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . 74.78 -44.93 1.56 Allowed Glycine 0 CA--C 1.52 0.348 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' DBB . . . . . 0.648 ' HG2' ' C ' ' A' ' 16' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' DAL . . . . . 0.646 ' HB2' ' O ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -78.37 33.07 0.19 Allowed 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.244 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.597 ' C ' ' CG ' ' A' ' 12' ' ' DBB . 77.8 mt-30 -137.74 -8.22 1.64 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.826 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' DBB . . . . . 0.687 ' O ' ' O ' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.687 ' O ' ' O ' ' A' ' 16' ' ' DBB . . . -26.23 161.47 0.0 OUTLIER Glycine 0 CA--C 1.527 0.8 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.553 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' DBU . . . . . 0.645 ' HG2' ' C ' ' A' ' 5' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.595 ' SG ' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER -99.27 -24.83 14.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 112.954 -1.93 . . . . 0.0 110.237 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.637 ' HB2' ' C ' ' A' ' 16' ' ' DBB . 1.5 m . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.632 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.513 ' O ' ' HG1' ' A' ' 18' ' ' DBU . 80.5 mtt85 -63.37 -41.02 98.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 110.701 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.3 mm -77.17 -0.98 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.501 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -82.29 111.17 18.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.539 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' DBU . . . . . 0.55 ' C ' ' H ' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.59 ' SG ' ' HD2' ' A' ' 7' ' ' PRO . 4.9 t -101.41 143.49 26.7 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.449 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.611 ' O ' ' CB ' ' A' ' 8' ' ' ALA . 52.6 Cg_exo -51.63 -8.57 0.28 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.874 2.382 . . . . 0.0 112.181 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.611 ' CB ' ' O ' ' A' ' 7' ' ' PRO . . . 91.37 28.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.496 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.64 16.79 55.61 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.27 -54.99 1.52 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.609 ' O ' ' N ' ' A' ' 13' ' ' DAL . . . -63.24 -35.25 91.82 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' DBB . . . . . 0.7 ' CG ' ' N ' ' A' ' 16' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' DAL . . . . . 0.609 ' N ' ' O ' ' A' ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.557 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 58.1 mp0 -76.5 9.72 2.54 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.856 0.36 . . . . 0.0 110.705 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.57 ' C ' ' CG ' ' A' ' 12' ' ' DBB . 92.3 mm-40 -92.7 -4.69 52.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.044 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' DBB . . . . . 0.759 ' O ' ' HB3' ' A' ' 20' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.601 ' O ' ' O ' ' A' ' 12' ' ' DBB . . . -23.63 142.92 0.01 OUTLIER Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' DBU . . . . . 0.513 ' HG1' ' O ' ' A' ' 2' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.641 ' SG ' ' O ' ' A' ' 19' ' ' CYS . 0.8 OUTLIER -172.33 31.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.609 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.759 ' HB3' ' O ' ' A' ' 16' ' ' DBB . 0.0 OUTLIER . . . . . 0 C--O 1.218 -0.556 0 CA-C-O 117.91 -1.043 . . . . 0.0 110.787 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.583 ' O ' ' CG ' ' A' ' 18' ' ' DBU . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.556 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 80.3 mtp85 -67.27 145.34 55.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.813 0.339 . . . . 0.0 110.572 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.578 ' HA ' ' O ' ' A' ' 6' ' ' CYS . 30.5 mm 73.4 -16.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.561 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.502 ' H ' ' C ' ' A' ' 2' ' ' ARG . 67.3 t0 -67.73 108.73 3.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.568 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' DBU . . . . . 0.604 ' C ' ' HA3' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.687 ' SG ' ' O ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -128.91 90.32 46.17 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.488 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.99 -2.83 13.1 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.846 2.364 . . . . 0.0 112.14 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.02 -39.69 72.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.578 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.514 ' O ' HD13 ' A' ' 3' ' ' ILE . . . -165.59 165.04 37.7 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.556 ' O ' ' CB ' ' A' ' 2' ' ' ARG . . . -63.54 -35.04 91.51 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 13' ' ' DAL . . . -62.18 -35.79 92.04 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' DBB . . . . . 0.674 ' CG ' ' N ' ' A' ' 16' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' DAL . . . . . 0.587 ' N ' ' O ' ' A' ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.446 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 59.8 mp0 -71.97 -7.1 46.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.823 0.344 . . . . 0.0 110.581 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.56 ' C ' ' CG ' ' A' ' 12' ' ' DBB . 99.7 mm-40 -70.79 -1.66 12.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.606 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' DBB . . . . . 0.674 ' N ' ' CG ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.604 ' HA3' ' C ' ' A' ' 5' ' ' DBU . . . -35.17 143.51 0.08 OUTLIER Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' DBU . . . . . 0.583 ' CG ' ' O ' ' A' ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.7 p -167.95 20.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.138 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 16' ' ' DBB . 1.2 p . . . . . 0 C--O 1.221 -0.423 0 CA-C-O 117.865 -1.064 . . . . 0.0 110.466 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.558 ' O ' ' HG1' ' A' ' 18' ' ' DBU . 29.3 mmt180 -62.58 -43.19 99.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.825 0.345 . . . . 0.0 110.615 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.527 ' CG1' ' HA2' ' A' ' 10' ' ' GLY . 6.1 mt -57.44 -16.2 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.428 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -55.42 -44.05 75.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.283 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.687 ' SG ' ' O ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -118.88 107.35 42.35 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.092 179.458 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.91 14.99 1.38 Allowed 'Trans proline' 0 C--N 1.304 -1.816 0 C-N-CA 122.855 2.37 . . . . 0.0 112.014 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.63 -51.94 6.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.616 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.5 ' C ' HG12 ' A' ' 3' ' ' ILE . . . 172.1 168.72 33.96 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.527 ' HA2' ' CG1' ' A' ' 3' ' ' ILE . . . -41.78 -23.51 0.13 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.655 ' C ' ' H ' ' A' ' 13' ' ' DAL . . . -92.88 51.08 2.56 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' DBB . . . . . 0.716 ' CG ' ' N ' ' A' ' 16' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' DAL . . . . . 0.655 ' H ' ' C ' ' A' ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -74.12 -2.47 24.68 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.103 -0.373 . . . . 0.0 110.791 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.586 ' C ' ' CG ' ' A' ' 12' ' ' DBB . 95.6 mm-40 -74.53 -6.0 45.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.566 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' DBB . . . . . 0.716 ' N ' ' CG ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.693 ' O ' ' C ' ' A' ' 18' ' ' DBU . . . -2.4 -116.37 0.0 OUTLIER Glycine 0 C--N 1.338 0.694 0 O-C-N 123.895 0.747 . . . . 0.0 111.285 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' DBU . . . . . 0.693 ' C ' ' O ' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.601 ' N ' ' O ' ' A' ' 17' ' ' GLY . 18.8 p -122.46 -25.8 4.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.58 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.617 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--O 1.219 -0.526 0 CA-C-O 117.924 -1.036 . . . . 0.0 110.612 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.596 ' NH2' ' O ' ' A' ' 10' ' ' GLY . 79.6 mtp85 -62.57 140.07 58.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.809 0.338 . . . . 0.0 110.543 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.559 ' HB ' ' O ' ' A' ' 2' ' ' ARG . 50.6 mm 73.38 -27.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.534 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.538 ' H ' ' C ' ' A' ' 2' ' ' ARG . 56.4 m-20 -63.32 -36.09 82.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.568 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' DBU . . . . . 0.617 ' C ' ' HA3' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.695 ' SG ' ' O ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -126.91 92.06 45.49 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.217 179.453 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -75.39 -8.48 19.65 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.845 2.364 . . . . 0.0 112.093 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.01 -38.73 91.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.579 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.16 163.52 36.88 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.596 ' O ' ' NH2' ' A' ' 2' ' ' ARG . . . -63.32 -33.7 87.97 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' A' ' 13' ' ' DAL . . . -63.39 -36.7 93.74 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' DBB . . . . . 0.667 ' CG ' ' N ' ' A' ' 16' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' DAL . . . . . 0.558 ' N ' ' O ' ' A' ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.464 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 56.5 mp0 -72.75 -3.42 25.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.81 0.338 . . . . 0.0 110.604 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.566 ' C ' ' CG ' ' A' ' 12' ' ' DBB . 99.1 mm-40 -74.17 -2.6 25.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.541 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' DBB . . . . . 0.667 ' N ' ' CG ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.617 ' HA3' ' C ' ' A' ' 5' ' ' DBU . . . -28.01 148.63 0.01 OUTLIER Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' DBU . . . . . 0.448 ' HG3' ' HA ' ' A' ' 2' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.8 p -149.31 -17.96 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.853 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 13' ' ' DAL . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.622 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.4 mmt85 -64.61 -41.5 96.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.833 0.349 . . . . 0.0 110.629 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.627 HG22 ' HA ' ' A' ' 7' ' ' PRO . 84.8 mt -72.29 -4.6 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.75 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 99.2 m-20 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.377 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.427 ' O ' HG23 ' A' ' 3' ' ' ILE . 9.5 p . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.848 0.356 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.627 ' HA ' HG22 ' A' ' 3' ' ' ILE . 49.1 Cg_endo -72.09 43.42 0.59 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.692 2.261 . . . . 0.0 111.878 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -114.11 -30.58 6.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.428 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.408 ' O ' HG12 ' A' ' 3' ' ' ILE . . . -167.86 161.1 34.87 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.613 ' HA2' HD11 ' A' ' 3' ' ' ILE . . . -64.69 -31.75 81.95 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.393 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.657 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.633 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 78.9 mm-40 . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 120.746 0.308 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 . . . . . 0 C--N 1.332 -0.18 0 CA-C-O 120.896 0.379 . . . . 0.0 110.417 179.779 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.633 ' SG ' ' N ' ' A' ' 14' ' ' GLU . 12.6 p . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.461 0.172 . . . . 0.0 111.315 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.313 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.574 ' O ' ' OD1' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.518 ' HB3' ' HA2' ' A' ' 10' ' ' GLY . 84.3 mtp180 -61.95 -36.2 80.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.832 0.348 . . . . 0.0 110.594 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.811 HD13 ' H ' ' A' ' 4' ' ' ASP . 0.2 OUTLIER -52.7 -36.66 23.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.516 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.811 ' H ' HD13 ' A' ' 3' ' ' ILE . 90.1 m-20 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.629 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 3' ' ' ILE . 22.5 p . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.793 0.33 . . . . 0.0 110.572 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -78.5 18.33 0.97 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.918 2.412 . . . . 0.0 112.175 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -85.92 -42.38 14.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.614 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.4 171.99 44.28 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.518 ' HA2' ' HB3' ' A' ' 2' ' ' ARG . . . -60.62 -43.14 99.31 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.638 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.827 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 20' ' ' CYS . 22.5 pt-20 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.874 0.368 . . . . 0.0 110.552 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.582 179.949 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 1.6 p . . . . . 0 N--CA 1.457 -0.08 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.621 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.849 -1.072 . . . . 0.0 110.564 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -63.86 -42.0 97.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.959 0.409 . . . . 0.0 110.825 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.699 HD11 ' HA2' ' A' ' 10' ' ' GLY . 41.0 mm -61.18 -23.93 31.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.482 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.532 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 98.1 m-20 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.317 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.968 0.413 . . . . 0.0 110.577 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.641 ' HA ' HG23 ' A' ' 3' ' ' ILE . 53.2 Cg_endo -73.4 39.65 0.49 Allowed 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 122.77 2.313 . . . . 0.0 112.01 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -109.0 -31.74 7.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.47 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.72 158.85 31.89 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.699 ' HA2' HD11 ' A' ' 3' ' ' ILE . . . -62.87 -30.27 76.69 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.627 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.746 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.679 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 80.5 tt0 . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.779 0.323 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.4 179.916 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.679 ' SG ' ' N ' ' A' ' 14' ' ' GLU . 15.3 p . . . . . 0 CA--C 1.527 0.095 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.533 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -59.48 -34.69 72.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.949 0.404 . . . . 0.0 110.302 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 3' ' ' ILE . 33.1 mm -63.02 -42.23 95.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.262 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 . . . . . 0 C--N 1.331 -0.214 0 CA-C-O 120.963 0.411 . . . . 0.0 110.572 -179.481 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.667 ' SG ' ' HD2' ' A' ' 7' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.134 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.697 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 36.1 Cg_exo -56.96 -25.69 63.96 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.748 2.299 . . . . 0.0 111.92 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 7' ' ' PRO . . . 99.05 43.17 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.403 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.23 31.93 6.92 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.97 -63.16 2.04 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.458 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.5 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.608 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 97.4 mt-10 . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.936 0.398 . . . . 0.0 110.288 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.265 179.333 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' A' ' 14' ' ' GLU . 15.4 p . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.714 0.293 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.427 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.571 ' N ' ' OD1' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.562 ' HB3' ' CA ' ' A' ' 10' ' ' GLY . 90.3 mtm-85 -64.38 -37.96 89.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 110.68 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.6 ' O ' ' N ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -67.26 -23.15 29.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.552 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 1' ' ' GLY . 98.8 m-20 . . . . . 0 N--CA 1.462 0.151 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.09 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.667 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.112 0 CA-C-O 121.165 0.507 . . . . 0.0 110.341 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.515 ' HA ' ' HB ' ' A' ' 3' ' ' ILE . 58.5 Cg_endo -80.06 12.58 2.43 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 123.057 2.504 . . . . 0.0 112.03 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.2 -11.69 37.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.622 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 3' ' ' ILE . . . 172.14 170.41 35.99 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.562 ' CA ' ' HB3' ' A' ' 2' ' ' ARG . . . -64.02 -39.7 97.49 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.394 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.802 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 . . . . . 0 N--CA 1.456 -0.138 0 CA-C-O 120.944 0.402 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 . . . . . 0 C--N 1.331 -0.218 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.643 179.554 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 10.0 p . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.763 0.316 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.54 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.589 ' CG ' ' O ' ' A' ' 10' ' ' GLY . 0.6 OUTLIER -69.17 -22.92 63.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.881 0.372 . . . . 0.0 110.702 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.56 ' CG2' ' HA ' ' A' ' 7' ' ' PRO . 5.1 mm -105.99 3.24 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.446 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 67.4 t0 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.373 179.957 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.543 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 30.3 p . . . . . 0 CA--C 1.522 -0.123 0 CA-C-O 120.869 0.366 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.56 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 38.1 Cg_endo -69.88 23.41 0.18 Allowed 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.719 2.279 . . . . 0.0 111.961 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.484 ' H ' ' C ' ' A' ' 6' ' ' CYS . . . -89.13 -41.97 11.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.764 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.58 162.13 31.8 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.589 ' O ' ' CG ' ' A' ' 2' ' ' ARG . . . -64.03 -32.4 84.05 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.57 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -179.568 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.839 0.352 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.584 179.861 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 10.4 p . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.771 0.32 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.653 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.543 ' O ' ' CG ' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -61.44 -22.92 65.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.913 0.387 . . . . 0.0 110.57 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.835 HG23 ' HB2' ' A' ' 8' ' ' ALA . 90.5 mt -62.95 -42.79 97.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.495 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.543 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 51.1 p30 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.568 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.661 ' SG ' ' HD2' ' A' ' 7' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.102 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.733 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 32.8 Cg_exo -56.25 -23.47 45.83 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.862 2.375 . . . . 0.0 112.151 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.835 ' HB2' HG23 ' A' ' 3' ' ' ILE . . . 94.45 44.22 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.469 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.68 33.12 6.48 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.55 -61.35 1.96 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.631 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.93 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.642 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 68.9 mm-40 . . . . . 0 N--CA 1.461 0.082 0 CA-C-O 120.907 0.384 . . . . 0.0 110.756 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.77 179.55 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.575 ' O ' ' C ' ' A' ' 20' ' ' CYS . 18.2 p . . . . . 0 CA--C 1.527 0.082 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.642 ' SG ' ' O ' ' A' ' 14' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.047 -0.978 . . . . 0.0 111.079 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -62.49 -43.56 98.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.784 0.326 . . . . 0.0 110.563 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.525 HG22 ' O ' ' A' ' 3' ' ' ILE . 71.4 mt -81.31 -7.67 10.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.508 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' A' ' 1' ' ' GLY . 65.1 t0 . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.347 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.442 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 26.4 p . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 121.044 0.449 . . . . 0.0 110.418 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.491 ' HA ' HG22 ' A' ' 3' ' ' ILE . 42.0 Cg_endo -70.82 42.44 0.41 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.823 2.349 . . . . 0.0 111.961 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -114.99 -29.15 6.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.584 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.64 158.62 31.65 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.99 -31.21 80.18 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.622 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.744 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.432 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 58.3 mp0 . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.848 0.356 . . . . 0.0 110.494 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.465 179.92 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 12.2 p . . . . . 0 N--CA 1.457 -0.075 0 CA-C-O 120.617 0.246 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.568 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.606 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -63.88 -38.78 92.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.786 0.327 . . . . 0.0 110.633 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 95.9 mt -66.21 -24.62 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.544 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 63.7 t0 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.532 179.9 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.672 ' SG ' ' HD2' ' A' ' 7' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.88 0.371 . . . . 0.0 110.537 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.686 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 32.6 Cg_exo -57.51 -26.29 71.01 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.929 2.419 . . . . 0.0 111.975 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.686 ' HB3' ' O ' ' A' ' 7' ' ' PRO . . . 102.33 55.92 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.665 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -115.06 24.96 10.32 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.63 -59.08 1.66 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.477 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 179.587 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.665 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 17.7 pt-20 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.904 0.383 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.517 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 80.9 mt-30 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.565 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.665 ' SG ' ' N ' ' A' ' 14' ' ' GLU . 13.5 p . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.937 0.399 . . . . 0.0 110.738 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.846 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.371 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.511 ' O ' ' HB ' ' A' ' 3' ' ' ILE . 90.3 mtm-85 -67.42 146.9 53.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.804 0.335 . . . . 0.0 110.424 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 6' ' ' CYS . 43.3 mm 73.06 -16.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.638 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.464 ' H ' ' C ' ' A' ' 2' ' ' ARG . 43.9 t0 . . . . . 0 C--N 1.332 -0.173 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.39 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.691 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.072 0 CA-C-O 121.24 0.543 . . . . 0.0 110.404 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.418 ' HA ' HG23 ' A' ' 3' ' ' ILE . 55.4 Cg_endo -73.73 -9.17 22.32 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.8 2.334 . . . . 0.0 111.325 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.97 -38.21 90.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.436 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.409 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . -174.41 157.06 24.39 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.717 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.99 -23.81 40.25 Favored Glycine 0 C--N 1.331 0.303 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.394 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 178.697 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 120.777 0.322 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.479 -179.951 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 1.7 p . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.458 0.17 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.402 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--O 1.221 -0.423 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.441 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.772 ' O ' HD12 ' A' ' 3' ' ' ILE . 90.5 mtm-85 -70.1 146.17 51.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 0.0 110.67 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.772 HD12 ' O ' ' A' ' 2' ' ' ARG . 1.2 mp 73.01 -5.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.593 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.522 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 55.1 m-20 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.35 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.754 0.311 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.501 ' HA ' HG23 ' A' ' 3' ' ' ILE . 39.4 Cg_endo -69.46 6.89 1.04 Allowed 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.753 2.302 . . . . 0.0 112.109 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.39 -37.89 89.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.587 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.0 -171.47 43.43 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.16 160.79 26.4 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.654 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 -179.532 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.653 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 47.6 mt-10 . . . . . 0 N--CA 1.461 0.103 0 CA-C-O 120.878 0.371 . . . . 0.0 110.499 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.305 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.644 ' SG ' ' O ' ' A' ' 19' ' ' CYS . 9.7 p . . . . . 0 N--CA 1.463 0.178 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.653 ' SG ' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.561 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -61.88 -43.07 99.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.768 0.318 . . . . 0.0 110.611 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.552 HD13 ' N ' ' A' ' 4' ' ' ASP . 0.1 OUTLIER -72.26 -14.73 17.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.344 -179.871 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.552 ' N ' HD13 ' A' ' 3' ' ' ILE . 4.6 t0 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.416 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.531 ' O ' ' HB ' ' A' ' 3' ' ' ILE . 1.4 p . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.897 0.38 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.515 ' HA ' ' HB ' ' A' ' 3' ' ' ILE . 39.1 Cg_endo -69.98 18.25 0.2 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.936 2.424 . . . . 0.0 112.149 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.505 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -107.92 -74.09 0.67 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.755 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.562 ' O ' ' C ' ' A' ' 10' ' ' GLY . . . -176.13 172.66 45.65 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.562 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . -27.41 -52.93 0.09 OUTLIER Glycine 0 CA--C 1.518 0.239 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.531 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.68 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 17.6 pt-20 . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 120.644 0.259 . . . . 0.0 110.714 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.785 -179.999 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.619 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 3.0 p . . . . . 0 CA--C 1.531 0.246 0 CA-C-O 120.591 0.234 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.221 -0.413 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.835 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 89.2 mtm-85 -61.13 -41.6 97.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.748 0.309 . . . . 0.0 110.563 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.823 ' C ' HD13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -94.21 -5.22 10.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.458 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 67.2 t0 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.498 -179.593 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.658 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.814 0.34 . . . . 0.0 110.404 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.13 43.36 1.52 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.761 2.307 . . . . 0.0 112.19 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -121.01 -34.83 3.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.526 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.84 -178.7 47.57 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.48 -40.8 99.19 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.57 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.934 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 . . . . . 0 N--CA 1.455 -0.197 0 CA-C-O 120.799 0.333 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 179.775 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.597 ' O ' ' C ' ' A' ' 20' ' ' CYS . 17.5 p . . . . . 0 N--CA 1.456 -0.131 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.597 ' C ' ' O ' ' A' ' 19' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 117.97 -1.015 . . . . 0.0 110.681 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.555 ' HG3' ' CA ' ' A' ' 10' ' ' GLY . 23.8 tpt180 -61.96 -42.78 99.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.294 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.533 ' H ' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -75.37 -15.32 15.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.846 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 3' ' ' ILE . 68.2 t0 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.832 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.654 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 121.185 0.517 . . . . 0.0 109.921 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -84.02 42.94 1.29 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 123.117 2.544 . . . . 0.0 112.381 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.501 ' CB ' ' OE1' ' A' ' 15' ' ' GLN . . . -126.7 -33.06 2.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.681 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.35 172.2 45.01 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.555 ' CA ' ' HG3' ' A' ' 2' ' ' ARG . . . -64.93 -38.32 95.36 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.461 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . . . . . . 0 CA--C 1.523 0.537 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.732 0.301 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.501 ' OE1' ' CB ' ' A' ' 8' ' ' ALA . 79.6 mt-30 . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.553 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.148 0 CA-C-O 120.979 0.419 . . . . 0.0 109.908 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.639 179.874 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.44 ' HA3' ' CB ' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.493 2.449 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -59.3 -42.79 92.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.981 0.42 . . . . 0.0 110.162 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.533 ' O ' ' O ' ' A' ' 6' ' ' CYS . 5.7 pt -102.07 -0.44 10.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.967 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.44 ' CB ' ' HA3' ' A' ' 1' ' ' GLY . 65.1 t0 . . . . . 0 C--N 1.333 -0.147 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.021 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.623 ' SG ' ' HD2' ' A' ' 7' ' ' PRO . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 120.909 0.385 . . . . 0.0 110.255 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.693 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 31.7 Cg_exo -57.56 -25.74 68.67 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 123.147 2.565 . . . . 0.0 112.239 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' A' ' 7' ' ' PRO . . . 100.05 46.85 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.902 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.98 20.9 48.98 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.79 -58.1 3.86 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.168 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 178.719 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.641 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 49.8 tp10 . . . . . 0 N--CA 1.455 -0.207 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.525 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 48.2 mt-30 . . . . . 0 N--CA 1.455 -0.194 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.402 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.552 ' SG ' ' N ' ' A' ' 14' ' ' GLU . 9.6 p . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.896 0.379 . . . . 0.0 110.522 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.641 ' SG ' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.497 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -64.01 -37.57 87.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.752 0.31 . . . . 0.0 110.463 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.592 HG13 ' N ' ' A' ' 6' ' ' CYS . 0.7 OUTLIER -100.04 1.54 10.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.09 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 3' ' ' ILE . 99.0 m-20 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.391 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.642 ' SG ' ' O ' ' A' ' 9' ' ' GLY . 1.6 p . . . . . 0 CA--C 1.529 0.146 0 CA-C-O 120.907 0.384 . . . . 0.0 110.017 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.479 ' HA ' ' HB ' ' A' ' 3' ' ' ILE . 45.9 Cg_endo -69.69 54.72 1.18 Allowed 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 123.217 2.612 . . . . 0.0 113.332 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.625 ' HB3' ' HB3' ' A' ' 15' ' ' GLN . . . -158.41 -36.81 0.07 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.8 0.333 . . . . 0.0 110.496 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.642 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . 158.71 -168.23 34.86 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.46 170.55 26.8 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.595 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . . . . . . 0 CA--C 1.52 0.348 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 . . . . . 0 CA--C 1.522 -0.104 0 CA-C-O 120.981 0.42 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.625 ' HB3' ' HB3' ' A' ' 8' ' ' ALA . 77.8 mt-30 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.826 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.595 ' SG ' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.8 0.333 . . . . 0.0 110.237 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 19' ' ' CYS . 1.5 m . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.632 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -63.37 -41.02 98.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 110.701 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.583 HG22 ' O ' ' A' ' 3' ' ' ILE . 49.3 mm -77.17 -0.98 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.501 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 45.6 t0 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.539 -179.656 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.592 ' SG ' ' HD2' ' A' ' 7' ' ' PRO . 4.9 t . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.936 0.398 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.736 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 52.6 Cg_exo -51.63 -8.57 0.28 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.874 2.382 . . . . 0.0 112.181 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 7' ' ' PRO . . . 91.37 28.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.496 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.64 16.79 55.61 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.27 -54.99 1.52 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.498 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.566 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.603 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 58.1 mp0 . . . . . 0 N--CA 1.455 -0.201 0 CA-C-O 120.856 0.36 . . . . 0.0 110.705 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.564 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 92.3 mm-40 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.044 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.641 ' SG ' ' O ' ' A' ' 19' ' ' CYS . 0.8 OUTLIER . . . . . 0 CA--C 1.519 -0.222 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.647 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.218 -0.556 0 CA-C-O 117.91 -1.043 . . . . 0.0 110.787 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.556 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 80.3 mtp85 -67.27 145.34 55.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.813 0.339 . . . . 0.0 110.572 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 6' ' ' CYS . 30.5 mm 73.4 -16.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.561 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' A' ' 2' ' ' ARG . 67.3 t0 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.568 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.687 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.857 0.36 . . . . 0.0 110.488 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.99 -2.83 13.1 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.846 2.364 . . . . 0.0 112.14 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.02 -39.69 72.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.578 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.521 ' O ' HD13 ' A' ' 3' ' ' ILE . . . -165.59 165.04 37.7 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.556 ' O ' ' CB ' ' A' ' 2' ' ' ARG . . . -63.54 -35.04 91.51 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.662 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.775 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.452 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 59.8 mp0 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.823 0.344 . . . . 0.0 110.581 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.606 179.957 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.409 0.147 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.221 -0.423 0 CA-C-O 117.865 -1.064 . . . . 0.0 110.466 -179.985 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -62.58 -43.19 99.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.825 0.345 . . . . 0.0 110.615 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.523 ' CG1' ' HA2' ' A' ' 10' ' ' GLY . 6.1 mt -57.44 -16.2 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.428 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 65.2 t0 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.283 -179.808 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.687 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 121.053 0.454 . . . . 0.0 110.092 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.91 14.99 1.38 Allowed 'Trans proline' 0 C--N 1.304 -1.816 0 C-N-CA 122.855 2.37 . . . . 0.0 112.014 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.63 -51.94 6.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.616 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.52 ' C ' HG12 ' A' ' 3' ' ' ILE . . . 172.1 168.72 33.96 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.523 ' HA2' ' CG1' ' A' ' 3' ' ' ILE . . . -41.78 -23.51 0.13 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . 0 CA--C 1.52 0.393 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 120.808 0.337 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.566 179.926 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 18.8 p . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.646 0.26 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.617 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--O 1.219 -0.526 0 CA-C-O 117.924 -1.036 . . . . 0.0 110.612 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.596 ' NH2' ' O ' ' A' ' 10' ' ' GLY . 79.6 mtp85 -62.57 140.07 58.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.809 0.338 . . . . 0.0 110.543 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.565 ' HB ' ' O ' ' A' ' 2' ' ' ARG . 50.6 mm 73.38 -27.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.534 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 56.4 m-20 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.568 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.695 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 121.115 0.483 . . . . 0.0 110.217 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.436 ' HA ' HG23 ' A' ' 3' ' ' ILE . 55.6 Cg_endo -75.39 -8.48 19.65 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.845 2.364 . . . . 0.0 112.093 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.01 -38.73 91.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.579 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.16 163.52 36.88 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.596 ' O ' ' NH2' ' A' ' 2' ' ' ARG . . . -63.32 -33.7 87.97 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.76 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.894 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.481 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 56.5 mp0 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.81 0.338 . . . . 0.0 110.604 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.541 -179.951 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.8 p . . . . . 0 CA--C 1.532 0.271 0 N-CA-C 110.853 -0.055 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.622 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.904 ' O ' ' HG3' ' A' ' 18' ' ' DBU . 28.4 mmt85 -64.61 -41.5 96.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.833 0.349 . . . . 0.0 110.629 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.627 HG22 ' HA ' ' A' ' 7' ' ' PRO . 84.8 mt -72.29 -4.6 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.75 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 99.2 m-20 -62.12 -42.41 99.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.377 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.691 ' HB3' ' C ' ' A' ' 16' ' ' DBB . 9.5 p -140.51 82.6 15.98 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.857 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.627 ' HA ' HG22 ' A' ' 3' ' ' ILE . 49.1 Cg_endo -72.09 43.42 0.59 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.692 2.261 . . . . 0.0 111.878 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -114.11 -30.58 6.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.428 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.408 ' O ' HG12 ' A' ' 3' ' ' ILE . . . -167.86 161.1 34.87 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.613 ' HA2' HD11 ' A' ' 3' ' ' ILE . . . -64.69 -31.75 81.95 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -55.18 -44.46 83.96 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' DBB . . . . . 0.832 ' HG2' ' HB2' ' A' ' 15' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' DAL . . . . . 0.611 ' C ' ' N ' ' A' ' 15' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.625 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 78.9 mm-40 -41.63 -17.88 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.448 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.832 ' HB2' ' HG2' ' A' ' 12' ' ' DBB . 98.5 mm-40 -53.96 -8.92 0.21 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.896 0.379 . . . . 0.0 110.417 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' DBB . . . . . 0.691 ' C ' ' HB3' ' A' ' 6' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.66 ' O ' ' C ' ' A' ' 18' ' ' DBU . . . 10.79 -123.49 0.01 OUTLIER Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' DBU . . . . . 0.904 ' HG3' ' O ' ' A' ' 2' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.625 ' SG ' ' N ' ' A' ' 14' ' ' GLU . 12.6 p -103.76 -12.13 17.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.315 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.568 ' HB3' ' C ' ' A' ' 16' ' ' DBB . 0.1 OUTLIER . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.313 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.574 ' O ' ' OD1' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.518 ' HB3' ' HA2' ' A' ' 10' ' ' GLY . 84.3 mtp180 -61.95 -36.2 80.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.832 0.348 . . . . 0.0 110.594 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.811 HD13 ' H ' ' A' ' 4' ' ' ASP . 0.2 OUTLIER -52.7 -36.66 23.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.516 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.811 ' H ' HD13 ' A' ' 3' ' ' ILE . 90.1 m-20 32.15 56.19 0.35 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.629 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' DBU . . . . . 0.518 ' O ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 1.213 ' SG ' ' HG2' ' A' ' 18' ' ' DBU . 22.5 p -68.04 109.2 3.55 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.572 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 5' ' ' DBU . 56.9 Cg_endo -78.5 18.33 0.97 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.918 2.412 . . . . 0.0 112.175 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -85.92 -42.38 14.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.614 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.4 171.99 44.28 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.518 ' HA2' ' HB3' ' A' ' 2' ' ' ARG . . . -60.62 -43.14 99.31 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -43.16 -72.54 0.31 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' DBB . . . . . 0.609 ' CG ' ' H ' ' A' ' 16' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' DAL . . . . . 0.606 ' C ' ' H ' ' A' ' 15' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 20' ' ' CYS . 22.5 pt-20 -53.51 -6.67 0.08 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.874 0.368 . . . . 0.0 110.552 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.606 ' H ' ' C ' ' A' ' 13' ' ' DAL . 76.4 mt-30 -54.97 -39.53 69.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.582 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' DBB . . . . . 0.641 ' O ' ' C ' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.749 ' O ' ' C ' ' A' ' 18' ' ' DBU . . . -10.35 -107.17 0.0 OUTLIER Glycine 0 CA--C 1.522 0.477 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' DBU . . . . . 1.213 ' HG2' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.616 ' N ' ' O ' ' A' ' 17' ' ' GLY . 1.6 p -118.95 -35.96 3.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.534 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.621 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.849 -1.072 . . . . 0.0 110.564 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.829 ' O ' ' HG3' ' A' ' 18' ' ' DBU . 99.4 mtt180 -63.86 -42.0 97.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.959 0.409 . . . . 0.0 110.825 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.699 HD11 ' HA2' ' A' ' 10' ' ' GLY . 41.0 mm -61.18 -23.93 31.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.482 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.8 ' O ' ' HG2' ' A' ' 5' ' ' DBU . 98.1 m-20 -57.74 81.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.317 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' DBU . . . . . 0.8 ' HG2' ' O ' ' A' ' 4' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.697 ' HB3' ' C ' ' A' ' 16' ' ' DBB . 9.0 p -128.99 83.54 65.88 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.577 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.641 ' HA ' HG23 ' A' ' 3' ' ' ILE . 53.2 Cg_endo -73.4 39.65 0.49 Allowed 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 122.77 2.313 . . . . 0.0 112.01 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -109.0 -31.74 7.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.47 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.72 158.85 31.89 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.699 ' HA2' HD11 ' A' ' 3' ' ' ILE . . . -62.87 -30.27 76.69 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.57 -44.36 93.89 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' DBB . . . . . 0.96 ' HA ' ' HG2' ' A' ' 18' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' DAL . . . . . 0.785 ' HB3' ' H ' ' A' ' 19' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.673 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 80.5 tt0 -39.3 -20.87 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.617 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.842 ' HB2' ' HG2' ' A' ' 12' ' ' DBB . 99.7 mm-40 -53.65 -9.57 0.22 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.4 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' DBB . . . . . 0.697 ' C ' ' HB3' ' A' ' 6' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.676 ' O ' ' C ' ' A' ' 18' ' ' DBU . . . 11.97 -126.44 0.01 OUTLIER Glycine 0 CA--C 1.521 0.429 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' DBU . . . . . 0.96 ' HG2' ' HA ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.785 ' H ' ' HB3' ' A' ' 13' ' ' DAL . 15.3 p -96.54 -12.98 23.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.583 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.577 ' HB3' ' C ' ' A' ' 16' ' ' DBB . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.533 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.898 ' O ' ' HG3' ' A' ' 18' ' ' DBU . 94.2 mtt-85 -59.48 -34.69 72.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.949 0.404 . . . . 0.0 110.302 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 3' ' ' ILE . 33.1 mm -63.02 -42.23 95.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.262 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -59.56 140.31 56.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.963 0.411 . . . . 0.0 110.572 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' DBU . . . . . 0.689 ' O ' ' HG2' ' A' ' 16' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.686 ' SG ' ' C ' ' A' ' 16' ' ' DBB . 0.5 OUTLIER -97.34 155.6 37.18 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.187 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.697 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 36.1 Cg_exo -56.96 -25.69 63.96 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.748 2.299 . . . . 0.0 111.92 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 7' ' ' PRO . . . 99.05 43.17 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.403 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.23 31.93 6.92 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.97 -63.16 2.04 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.469 ' C ' ' N ' ' A' ' 13' ' ' DAL . . . -63.26 -39.38 97.8 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' DBB . . . . . 0.906 ' HA ' ' HG2' ' A' ' 18' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' DAL . . . . . 0.677 ' HB3' ' H ' ' A' ' 19' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.608 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 97.4 mt-10 -39.64 -20.55 0.01 OUTLIER 'General case' 0 C--N 1.341 0.233 0 CA-C-O 120.936 0.398 . . . . 0.0 110.288 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.822 ' HB2' ' HG3' ' A' ' 12' ' ' DBB . 84.1 mt-30 -54.52 -8.92 0.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.265 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' DBB . . . . . 0.689 ' HG2' ' O ' ' A' ' 5' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.635 ' O ' ' C ' ' A' ' 18' ' ' DBU . . . 9.57 -118.45 0.01 OUTLIER Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' DBU . . . . . 0.906 ' HG2' ' HA ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.677 ' H ' ' HB3' ' A' ' 13' ' ' DAL . 15.4 p -116.19 -10.55 11.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.978 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.594 ' N ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.427 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.571 ' N ' ' OD1' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.571 ' O ' ' HG1' ' A' ' 18' ' ' DBU . 90.3 mtm-85 -64.38 -37.96 89.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 110.68 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.6 ' O ' ' N ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -67.26 -23.15 29.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.552 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 1.114 ' O ' ' HG3' ' A' ' 18' ' ' DBU . 98.8 m-20 -21.75 113.49 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.09 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' DBU . . . . . 0.618 ' C ' ' HA3' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.667 ' SG ' ' O ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -104.25 96.97 10.67 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.341 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 5' ' ' DBU . 58.5 Cg_endo -80.06 12.58 2.43 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 123.057 2.504 . . . . 0.0 112.03 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.2 -11.69 37.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.622 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 3' ' ' ILE . . . 172.14 170.41 35.99 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.562 ' CA ' ' HB3' ' A' ' 2' ' ' ARG . . . -64.02 -39.7 97.49 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.7 -76.09 0.27 Allowed Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' DBB . . . . . 0.75 ' HG2' ' H ' ' A' ' 16' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' DAL . . . . . 0.517 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -72.86 -4.05 29.38 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 120.499 -0.48 . . . . 0.0 109.973 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.688 ' C ' ' HG1' ' A' ' 12' ' ' DBB . 89.2 mt-30 -71.15 -6.96 43.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.643 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' DBB . . . . . 0.75 ' H ' ' HG2' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.618 ' HA3' ' C ' ' A' ' 5' ' ' DBU . . . -32.7 162.24 0.0 OUTLIER Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.762 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' DBU . . . . . 1.114 ' HG3' ' O ' ' A' ' 4' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' A' ' 13' ' ' DAL . 10.0 p -136.97 3.63 2.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.728 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.68 ' HB2' ' C ' ' A' ' 16' ' ' DBB . 0.8 OUTLIER . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.54 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.878 ' HA ' ' HG1' ' A' ' 18' ' ' DBU . 0.6 OUTLIER -69.17 -22.92 63.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.881 0.372 . . . . 0.0 110.702 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.56 ' CG2' ' HA ' ' A' ' 7' ' ' PRO . 5.1 mm -105.99 3.24 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.446 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -85.09 106.65 16.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.373 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' DBU . . . . . 0.51 ' CA ' ' HA3' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.648 ' SG ' ' O ' ' A' ' 17' ' ' GLY . 30.3 p -150.86 78.65 7.33 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.916 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.56 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 38.1 Cg_endo -69.88 23.41 0.18 Allowed 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.719 2.279 . . . . 0.0 111.961 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.484 ' H ' ' C ' ' A' ' 6' ' ' CYS . . . -89.13 -41.97 11.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.764 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.58 162.13 31.8 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.589 ' O ' ' CG ' ' A' ' 2' ' ' ARG . . . -64.03 -32.4 84.05 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -53.7 -43.37 69.08 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' DBB . . . . . 0.683 ' HG2' ' HB2' ' A' ' 15' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' DAL . . . . . 0.513 ' HB3' ' O ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.404 ' C ' ' N ' ' A' ' 16' ' ' DBB . 45.0 mt-10 -59.19 -17.12 24.76 Favored 'General case' 0 C--O 1.232 0.165 0 O-C-N 122.054 -0.404 . . . . 0.0 110.581 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.683 ' HB2' ' HG2' ' A' ' 12' ' ' DBB . 84.6 mt-30 -57.14 -6.57 0.4 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.584 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' DBB . . . . . 0.562 ' O ' ' O ' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.648 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . -28.04 149.6 0.01 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' DBU . . . . . 0.878 ' HG1' ' HA ' ' A' ' 2' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 10.4 p -133.73 -20.84 1.99 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.06 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.488 ' HB3' ' O ' ' A' ' 16' ' ' DBB . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.653 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.543 ' O ' ' CG ' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.532 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 95.0 mtt180 -61.44 -22.92 65.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.913 0.387 . . . . 0.0 110.57 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.835 HG23 ' HB2' ' A' ' 8' ' ' ALA . 90.5 mt -62.95 -42.79 97.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.495 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 5' ' ' DBU . 51.1 p30 -43.8 -20.85 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.568 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' DBU . . . . . 0.654 ' C ' ' H ' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.692 ' SG ' ' C ' ' A' ' 16' ' ' DBB . 0.5 OUTLIER -86.69 154.25 55.87 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.102 179.838 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.733 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 32.8 Cg_exo -56.25 -23.47 45.83 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.862 2.375 . . . . 0.0 112.151 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.835 ' HB2' HG23 ' A' ' 3' ' ' ILE . . . 94.45 44.22 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.469 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.68 33.12 6.48 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.55 -61.35 1.96 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.406 ' C ' ' N ' ' A' ' 13' ' ' DAL . . . -64.42 -38.74 96.2 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' DBB . . . . . 0.915 ' HA ' ' HG2' ' A' ' 18' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' DAL . . . . . 0.747 ' HB3' ' H ' ' A' ' 19' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.642 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 68.9 mm-40 -38.57 -21.36 0.01 OUTLIER 'General case' 0 C--N 1.34 0.181 0 CA-C-O 120.907 0.384 . . . . 0.0 110.756 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.869 ' HB2' ' HG3' ' A' ' 12' ' ' DBB . 40.7 mt-30 -50.94 -24.61 3.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.77 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' DBB . . . . . 0.723 ' C ' ' HB2' ' A' ' 20' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.664 ' O ' ' C ' ' A' ' 18' ' ' DBU . . . 6.56 -119.69 0.01 OUTLIER Glycine 0 N--CA 1.463 0.486 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' DBU . . . . . 0.915 ' HG2' ' HA ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.747 ' H ' ' HB3' ' A' ' 13' ' ' DAL . 18.2 p -105.33 -21.41 13.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.186 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.723 ' HB2' ' C ' ' A' ' 16' ' ' DBB . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.047 -0.978 . . . . 0.0 111.079 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.661 ' O ' ' HG3' ' A' ' 18' ' ' DBU . 83.8 mtt85 -62.49 -43.56 98.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.784 0.326 . . . . 0.0 110.563 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.525 ' O ' HG22 ' A' ' 3' ' ' ILE . 71.4 mt -81.31 -7.67 10.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.508 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' A' ' 1' ' ' GLY . 65.1 t0 -61.75 -42.65 99.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.347 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.67 ' SG ' ' O ' ' A' ' 17' ' ' GLY . 26.4 p -125.71 78.16 69.22 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.418 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.491 ' HA ' HG22 ' A' ' 3' ' ' ILE . 42.0 Cg_endo -70.82 42.44 0.41 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.823 2.349 . . . . 0.0 111.961 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -114.99 -29.15 6.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.584 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.64 158.62 31.65 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.99 -31.21 80.18 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -54.7 -42.82 79.02 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' DBB . . . . . 0.67 ' HG2' ' HB2' ' A' ' 15' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' DAL . . . . . 0.476 ' HB3' ' O ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.401 ' C ' ' N ' ' A' ' 16' ' ' DBB . 58.3 mp0 -60.64 -16.52 39.55 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.848 0.356 . . . . 0.0 110.494 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.67 ' HB2' ' HG2' ' A' ' 12' ' ' DBB . 85.3 mt-30 -58.79 -4.12 0.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.465 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' DBB . . . . . 0.554 ' C ' ' HB3' ' A' ' 6' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.67 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . -28.15 148.53 0.01 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' DBU . . . . . 0.661 ' HG3' ' O ' ' A' ' 2' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 12.2 p -135.1 -10.75 2.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.944 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.568 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.606 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.492 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 83.4 mtp180 -63.88 -38.78 92.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.786 0.327 . . . . 0.0 110.633 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 95.9 mt -66.21 -24.62 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.544 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -62.71 -41.48 99.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.532 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.746 ' SG ' ' C ' ' A' ' 16' ' ' DBB . 0.1 OUTLIER -75.95 158.73 82.07 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.537 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.686 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 32.6 Cg_exo -57.51 -26.29 71.01 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.929 2.419 . . . . 0.0 111.975 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.686 ' HB3' ' O ' ' A' ' 7' ' ' PRO . . . 102.33 55.92 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.665 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -115.06 24.96 10.32 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.63 -59.08 1.66 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 13' ' ' DAL . . . -62.77 -33.95 88.33 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' DBB . . . . . 0.866 ' HG3' ' HB2' ' A' ' 15' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' DAL . . . . . 0.614 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.665 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 17.7 pt-20 -37.65 -22.97 0.01 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.904 0.383 . . . . 0.0 110.257 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.866 ' HB2' ' HG3' ' A' ' 12' ' ' DBB . 80.9 mt-30 -54.65 -7.9 0.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.565 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' DBB . . . . . 0.746 ' C ' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.623 ' O ' ' O ' ' A' ' 12' ' ' DBB . . . -35.83 132.53 0.72 Allowed Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' DBU . . . . . 0.738 ' HG2' ' HA ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.665 ' SG ' ' N ' ' A' ' 14' ' ' GLU . 13.5 p -140.8 8.56 2.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.738 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.846 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.371 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.627 ' HA ' ' HG1' ' A' ' 18' ' ' DBU . 90.3 mtm-85 -67.42 146.9 53.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.804 0.335 . . . . 0.0 110.424 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 6' ' ' CYS . 43.3 mm 73.06 -16.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.638 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.464 ' H ' ' C ' ' A' ' 2' ' ' ARG . 43.9 t0 -63.52 -40.56 97.37 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.39 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' DBU . . . . . 0.61 ' C ' ' HA3' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.691 ' SG ' ' O ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -111.12 88.38 8.41 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.404 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.418 ' HA ' HG23 ' A' ' 3' ' ' ILE . 55.4 Cg_endo -73.73 -9.17 22.32 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.8 2.334 . . . . 0.0 111.325 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.97 -38.21 90.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.436 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.409 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . -174.41 157.06 24.39 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.717 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.99 -23.81 40.25 Favored Glycine 0 C--N 1.331 0.303 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 13' ' ' DAL . . . -87.22 51.74 4.27 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' DBB . . . . . 0.681 ' CG ' ' H ' ' A' ' 16' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' DAL . . . . . 0.57 ' N ' ' O ' ' A' ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -75.0 -5.03 41.79 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.405 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.657 ' C ' ' HG1' ' A' ' 12' ' ' DBB . 86.3 mt-30 -72.86 -8.04 53.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.479 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' DBB . . . . . 0.681 ' H ' ' CG ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.61 ' HA3' ' C ' ' A' ' 5' ' ' DBU . . . -31.68 156.71 0.0 OUTLIER Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' DBU . . . . . 0.627 ' HG1' ' HA ' ' A' ' 2' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 1.7 p -156.65 -31.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.039 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.54 ' HB3' ' O ' ' A' ' 13' ' ' DAL . 0.5 OUTLIER . . . . . 0 C--O 1.221 -0.423 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.441 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.772 ' O ' HD12 ' A' ' 3' ' ' ILE . 90.5 mtm-85 -70.1 146.17 51.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 0.0 110.67 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.772 HD12 ' O ' ' A' ' 2' ' ' ARG . 1.2 mp 73.01 -5.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.593 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.522 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 55.1 m-20 -61.71 -39.87 93.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.35 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' DBU . . . . . 0.673 ' C ' ' H ' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.682 ' SG ' ' N ' ' A' ' 16' ' ' DBB . 7.8 t -117.92 57.89 2.71 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.273 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.562 ' HD3' ' C ' ' A' ' 5' ' ' DBU . 39.4 Cg_endo -69.46 6.89 1.04 Allowed 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.753 2.302 . . . . 0.0 112.109 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.39 -37.89 89.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.587 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.0 -171.47 43.43 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.408 ' C ' ' H1 ' ' A' ' 12' ' ' DBB . . . -61.16 160.79 26.4 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.613 ' O ' ' N ' ' A' ' 13' ' ' DAL . . . 75.55 -25.69 1.38 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' DBB . . . . . 0.991 ' HA ' ' HG2' ' A' ' 18' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' DAL . . . . . 0.616 ' HB3' ' N ' ' A' ' 19' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.655 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 47.6 mt-10 -43.74 -15.42 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.103 0 CA-C-O 120.878 0.371 . . . . 0.0 110.499 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.815 ' HB2' ' HG3' ' A' ' 12' ' ' DBB . 0.4 OUTLIER -54.4 -33.82 60.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.305 179.773 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' DBB . . . . . 0.709 ' C ' ' HB2' ' A' ' 20' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.79 ' O ' ' C ' ' A' ' 18' ' ' DBU . . . -16.29 -99.23 0.01 OUTLIER Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.039 -0.825 . . . . 0.0 111.039 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' DBU . . . . . 0.991 ' HG2' ' HA ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.644 ' SG ' ' O ' ' A' ' 19' ' ' CYS . 9.7 p -139.16 50.99 1.8 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.658 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.709 ' HB2' ' C ' ' A' ' 16' ' ' DBB . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.561 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -61.88 -43.07 99.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.768 0.318 . . . . 0.0 110.611 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.552 HD13 ' N ' ' A' ' 4' ' ' ASP . 0.1 OUTLIER -72.26 -14.73 17.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.344 -179.871 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.584 ' O ' ' CG ' ' A' ' 18' ' ' DBU . 4.6 t0 66.47 43.56 2.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.416 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.565 ' HB3' ' H ' ' A' ' 18' ' ' DBU . 1.4 p -100.83 140.61 21.48 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.403 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.515 ' HA ' ' HB ' ' A' ' 3' ' ' ILE . 39.1 Cg_endo -69.98 18.25 0.2 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.936 2.424 . . . . 0.0 112.149 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.505 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -107.92 -74.09 0.67 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.755 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.562 ' O ' ' C ' ' A' ' 10' ' ' GLY . . . -176.13 172.66 45.65 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.562 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . -27.41 -52.93 0.09 OUTLIER Glycine 0 CA--C 1.518 0.239 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.494 ' O ' ' N ' ' A' ' 13' ' ' DAL . . . -73.78 55.96 2.15 Favored Glycine 0 CA--C 1.523 0.531 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' DBB . . . . . 0.903 ' HA ' ' HG2' ' A' ' 18' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' DAL . . . . . 0.599 ' HB3' ' N ' ' A' ' 19' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 17.6 pt-20 -72.0 -1.86 16.12 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.714 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.542 ' HB2' ' CG ' ' A' ' 12' ' ' DBB . 98.2 mm-40 -70.11 -10.51 59.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.785 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' DBB . . . . . 0.722 ' C ' ' HB2' ' A' ' 20' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.713 ' O ' ' C ' ' A' ' 18' ' ' DBU . . . -6.2 -109.15 0.0 OUTLIER Glycine 0 N--CA 1.466 0.655 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' DBU . . . . . 0.903 ' HG2' ' HA ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.619 ' SG ' ' O ' ' A' ' 19' ' ' CYS . 3.0 p -132.89 40.0 3.27 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.184 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.722 ' HB2' ' C ' ' A' ' 16' ' ' DBB . 0.1 OUTLIER . . . . . 0 C--O 1.221 -0.413 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.835 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.699 ' O ' ' HG1' ' A' ' 18' ' ' DBU . 89.2 mtm-85 -61.13 -41.6 97.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.748 0.309 . . . . 0.0 110.563 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.823 HD13 ' C ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -94.21 -5.22 10.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.458 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -60.35 -43.99 95.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.498 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' DBU . . . . . 0.402 ' C ' ' H ' ' A' ' 18' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.658 ' SG ' ' O ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -118.01 122.45 30.46 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.404 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.13 43.36 1.52 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.761 2.307 . . . . 0.0 112.19 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -121.01 -34.83 3.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.526 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.84 -178.7 47.57 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.48 -40.8 99.19 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.61 -73.97 0.42 Allowed Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' DBB . . . . . 0.799 ' CG ' ' H ' ' A' ' 16' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' DAL . . . . . 0.447 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -69.13 -5.72 24.06 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.799 0.333 . . . . 0.0 110.398 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.615 ' HB2' ' CG ' ' A' ' 12' ' ' DBB . 79.5 mt-30 -61.77 -28.09 69.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' DBB . . . . . 0.799 ' H ' ' CG ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.676 ' O ' ' C ' ' A' ' 18' ' ' DBU . . . -3.03 -115.42 0.0 OUTLIER Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' DBU . . . . . 0.699 ' HG1' ' O ' ' A' ' 2' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.597 ' O ' ' C ' ' A' ' 20' ' ' CYS . 17.5 p -106.52 -29.68 9.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.709 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.735 ' HB2' ' C ' ' A' ' 16' ' ' DBB . 0.8 OUTLIER . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 117.97 -1.015 . . . . 0.0 110.681 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.555 ' HG3' ' CA ' ' A' ' 10' ' ' GLY . 23.8 tpt180 -61.96 -42.78 99.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.294 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.533 HD13 ' H ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -75.37 -15.32 15.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.846 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 1.097 ' O ' ' HG3' ' A' ' 18' ' ' DBU . 68.2 t0 -38.81 123.72 1.3 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.832 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' DBU . . . . . 0.595 ' C ' ' HA3' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.776 ' HB3' ' HG2' ' A' ' 18' ' ' DBU . 0.0 OUTLIER -117.25 104.07 50.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.921 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -84.02 42.94 1.29 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 123.117 2.544 . . . . 0.0 112.381 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.501 ' CB ' ' OE1' ' A' ' 15' ' ' GLN . . . -126.7 -33.06 2.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.681 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.35 172.2 45.01 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.555 ' CA ' ' HG3' ' A' ' 2' ' ' ARG . . . -64.93 -38.32 95.36 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.461 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -61.22 -45.21 96.96 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' DBB . . . . . 0.782 ' O ' ' HB3' ' A' ' 13' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' DAL . . . . . 0.782 ' HB3' ' O ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -78.39 27.55 0.2 Allowed 'General case' 0 C--O 1.231 0.116 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.472 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.642 ' C ' ' HG1' ' A' ' 12' ' ' DBB . 79.6 mt-30 -132.97 -3.77 3.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.553 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' DBB . . . . . 0.675 ' C ' ' HG3' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.67 ' O ' ' O ' ' A' ' 16' ' ' DBB . . . -24.96 160.15 0.0 OUTLIER Glycine 0 CA--C 1.526 0.743 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.859 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' DBU . . . . . 1.097 ' HG3' ' O ' ' A' ' 4' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.62 ' SG ' ' C ' ' A' ' 12' ' ' DBB . 0.1 OUTLIER -98.7 -27.25 14.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 111.422 -2.626 . . . . 0.0 109.908 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.616 ' HB2' ' C ' ' A' ' 16' ' ' DBB . 1.5 m . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.639 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.44 ' HA3' ' CB ' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.493 2.449 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.862 ' HG2' ' HG3' ' A' ' 18' ' ' DBU . 16.5 ttm180 -59.3 -42.79 92.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.981 0.42 . . . . 0.0 110.162 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.533 ' O ' ' O ' ' A' ' 6' ' ' CYS . 5.7 pt -102.07 -0.44 10.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.967 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.44 ' CB ' ' HA3' ' A' ' 1' ' ' GLY . 65.1 t0 -63.02 -43.34 99.01 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.021 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.623 ' SG ' ' HD2' ' A' ' 7' ' ' PRO . 0.3 OUTLIER -78.76 155.11 78.33 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.255 179.794 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.693 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 31.7 Cg_exo -57.56 -25.74 68.67 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 123.147 2.565 . . . . 0.0 112.239 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' A' ' 7' ' ' PRO . . . 100.05 46.85 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.902 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.98 20.9 48.98 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.79 -58.1 3.86 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.535 ' O ' ' C ' ' A' ' 12' ' ' DBB . . . -65.31 -33.69 87.4 Favored Glycine 0 CA--C 1.517 0.168 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' DBB . . . . . 0.797 ' HG3' ' HB2' ' A' ' 15' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' DAL . . . . . 0.644 ' C ' ' N ' ' A' ' 15' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.641 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 49.8 tp10 -41.0 -21.44 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.797 ' HB2' ' HG3' ' A' ' 12' ' ' DBB . 48.2 mt-30 -52.25 -9.74 0.11 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.402 178.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' DBB . . . . . 0.645 ' C ' ' HB2' ' A' ' 20' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.583 ' O ' ' O ' ' A' ' 12' ' ' DBB . . . -24.37 142.19 0.01 OUTLIER Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' DBU . . . . . 0.862 ' HG3' ' HG2' ' A' ' 2' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.552 ' SG ' ' N ' ' A' ' 14' ' ' GLU . 9.6 p -120.49 -7.12 9.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.522 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.645 ' HB2' ' C ' ' A' ' 16' ' ' DBB . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.497 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -64.01 -37.57 87.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.752 0.31 . . . . 0.0 110.463 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.592 HG13 ' N ' ' A' ' 6' ' ' CYS . 0.7 OUTLIER -100.04 1.54 10.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.09 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.78 ' O ' ' HG1' ' A' ' 18' ' ' DBU . 99.0 m-20 63.42 34.08 13.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.391 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' DBU . . . . . 0.672 ' CA ' ' HG3' ' A' ' 18' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.672 ' HB3' ' HG2' ' A' ' 18' ' ' DBU . 1.6 p -114.01 134.35 22.17 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.017 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.479 ' HA ' ' HB ' ' A' ' 3' ' ' ILE . 45.9 Cg_endo -69.69 54.72 1.18 Allowed 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 123.217 2.612 . . . . 0.0 113.332 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.625 ' HB3' ' HB3' ' A' ' 15' ' ' GLN . . . -158.41 -36.81 0.07 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.8 0.333 . . . . 0.0 110.496 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.643 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . 158.71 -168.23 34.86 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.568 ' C ' ' H1 ' ' A' ' 12' ' ' DBB . . . -65.46 170.55 26.8 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.595 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . 74.78 -44.93 1.56 Allowed Glycine 0 CA--C 1.52 0.348 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' DBB . . . . . 0.788 ' O ' ' HB3' ' A' ' 13' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' DAL . . . . . 0.788 ' HB3' ' O ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -78.37 33.07 0.19 Allowed 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.244 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.625 ' HB3' ' HB3' ' A' ' 8' ' ' ALA . 77.8 mt-30 -137.74 -8.22 1.64 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.826 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' DBB . . . . . 0.687 ' O ' ' O ' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.687 ' O ' ' O ' ' A' ' 16' ' ' DBB . . . -26.23 161.47 0.0 OUTLIER Glycine 0 CA--C 1.527 0.8 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.553 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' DBU . . . . . 0.78 ' HG1' ' O ' ' A' ' 4' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.595 ' SG ' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER -99.27 -24.83 14.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 112.954 -1.93 . . . . 0.0 110.237 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.647 ' HB2' ' C ' ' A' ' 16' ' ' DBB . 1.5 m . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.632 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.438 ' O ' ' HG3' ' A' ' 18' ' ' DBU . 80.5 mtt85 -63.37 -41.02 98.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 110.701 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.583 ' O ' HG22 ' A' ' 3' ' ' ILE . 49.3 mm -77.17 -0.98 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.501 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -82.29 111.17 18.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.539 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' DBU . . . . . 0.611 ' C ' ' H ' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.592 ' SG ' ' HD2' ' A' ' 7' ' ' PRO . 4.9 t -101.41 143.49 26.7 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.449 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.736 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 52.6 Cg_exo -51.63 -8.57 0.28 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.874 2.382 . . . . 0.0 112.181 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 7' ' ' PRO . . . 91.37 28.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.496 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.64 16.79 55.61 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.27 -54.99 1.52 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.609 ' O ' ' N ' ' A' ' 13' ' ' DAL . . . -63.24 -35.25 91.82 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' DBB . . . . . 0.747 ' HG2' ' H ' ' A' ' 16' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' DAL . . . . . 0.609 ' N ' ' O ' ' A' ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.603 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 58.1 mp0 -76.5 9.72 2.54 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.856 0.36 . . . . 0.0 110.705 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.68 ' C ' ' HG1' ' A' ' 12' ' ' DBB . 92.3 mm-40 -92.7 -4.69 52.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.044 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' DBB . . . . . 0.784 ' O ' ' HB3' ' A' ' 20' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.611 ' H ' ' C ' ' A' ' 5' ' ' DBU . . . -23.63 142.92 0.01 OUTLIER Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' DBU . . . . . 0.438 ' HG3' ' O ' ' A' ' 2' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.641 ' SG ' ' O ' ' A' ' 19' ' ' CYS . 0.8 OUTLIER -172.33 31.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.609 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.784 ' HB3' ' O ' ' A' ' 16' ' ' DBB . 0.0 OUTLIER . . . . . 0 C--O 1.218 -0.556 0 CA-C-O 117.91 -1.043 . . . . 0.0 110.787 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.583 ' O ' ' CG ' ' A' ' 18' ' ' DBU . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.556 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 80.3 mtp85 -67.27 145.34 55.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.813 0.339 . . . . 0.0 110.572 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 6' ' ' CYS . 30.5 mm 73.4 -16.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.561 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' A' ' 2' ' ' ARG . 67.3 t0 -67.73 108.73 3.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.568 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' DBU . . . . . 0.606 ' C ' ' HA3' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.687 ' SG ' ' O ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -128.91 90.32 46.17 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.488 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.99 -2.83 13.1 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.846 2.364 . . . . 0.0 112.14 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.02 -39.69 72.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.578 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.521 ' O ' HD13 ' A' ' 3' ' ' ILE . . . -165.59 165.04 37.7 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.556 ' O ' ' CB ' ' A' ' 2' ' ' ARG . . . -63.54 -35.04 91.51 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 13' ' ' DAL . . . -62.18 -35.79 92.04 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' DBB . . . . . 0.753 ' HG1' ' C ' ' A' ' 15' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' DAL . . . . . 0.587 ' N ' ' O ' ' A' ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.401 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 59.8 mp0 -71.97 -7.1 46.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.823 0.344 . . . . 0.0 110.581 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.753 ' C ' ' HG1' ' A' ' 12' ' ' DBB . 99.7 mm-40 -70.79 -1.66 12.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.606 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' DBB . . . . . 0.674 ' N ' ' CG ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.606 ' HA3' ' C ' ' A' ' 5' ' ' DBU . . . -35.17 143.51 0.08 OUTLIER Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' DBU . . . . . 0.583 ' CG ' ' O ' ' A' ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.7 p -167.95 20.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.138 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.526 ' HB3' ' O ' ' A' ' 16' ' ' DBB . 1.2 p . . . . . 0 C--O 1.221 -0.423 0 CA-C-O 117.865 -1.064 . . . . 0.0 110.466 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.81 ' O ' ' HG3' ' A' ' 18' ' ' DBU . 29.3 mmt180 -62.58 -43.19 99.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.825 0.345 . . . . 0.0 110.615 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.523 ' CG1' ' HA2' ' A' ' 10' ' ' GLY . 6.1 mt -57.44 -16.2 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.428 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -55.42 -44.05 75.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.283 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.687 ' SG ' ' O ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -118.88 107.35 42.35 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.092 179.458 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.91 14.99 1.38 Allowed 'Trans proline' 0 C--N 1.304 -1.816 0 C-N-CA 122.855 2.37 . . . . 0.0 112.014 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.63 -51.94 6.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.616 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.52 ' C ' HG12 ' A' ' 3' ' ' ILE . . . 172.1 168.72 33.96 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.523 ' HA2' ' CG1' ' A' ' 3' ' ' ILE . . . -41.78 -23.51 0.13 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 9' ' ' GLY . . . -92.88 51.08 2.56 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' DBB . . . . . 1.009 ' HA ' ' HG2' ' A' ' 18' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' DAL . . . . . 0.741 ' HB3' ' H ' ' A' ' 19' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -74.12 -2.47 24.68 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.103 -0.373 . . . . 0.0 110.791 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.647 ' C ' ' HG1' ' A' ' 12' ' ' DBB . 95.6 mm-40 -74.53 -6.0 45.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.566 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' DBB . . . . . 0.716 ' N ' ' CG ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.693 ' O ' ' C ' ' A' ' 18' ' ' DBU . . . -2.4 -116.37 0.0 OUTLIER Glycine 0 C--N 1.338 0.694 0 O-C-N 123.895 0.747 . . . . 0.0 111.285 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' DBU . . . . . 1.009 ' HG2' ' HA ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.741 ' H ' ' HB3' ' A' ' 13' ' ' DAL . 18.8 p -122.46 -25.8 4.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.58 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.617 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--O 1.219 -0.526 0 CA-C-O 117.924 -1.036 . . . . 0.0 110.612 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.596 ' NH2' ' O ' ' A' ' 10' ' ' GLY . 79.6 mtp85 -62.57 140.07 58.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.809 0.338 . . . . 0.0 110.543 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.565 ' HB ' ' O ' ' A' ' 2' ' ' ARG . 50.6 mm 73.38 -27.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.534 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 56.4 m-20 -63.32 -36.09 82.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.568 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' DBU . . . . . 0.621 ' C ' ' HA3' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.695 ' SG ' ' O ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -126.91 92.06 45.49 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.217 179.453 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.436 ' HA ' HG23 ' A' ' 3' ' ' ILE . 55.6 Cg_endo -75.39 -8.48 19.65 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.845 2.364 . . . . 0.0 112.093 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.01 -38.73 91.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.579 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.16 163.52 36.88 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.596 ' O ' ' NH2' ' A' ' 2' ' ' ARG . . . -63.32 -33.7 87.97 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' A' ' 13' ' ' DAL . . . -63.39 -36.7 93.74 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' DBB . . . . . 0.754 ' HG1' ' C ' ' A' ' 15' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' DAL . . . . . 0.558 ' N ' ' O ' ' A' ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.464 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 56.5 mp0 -72.75 -3.42 25.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.81 0.338 . . . . 0.0 110.604 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.754 ' C ' ' HG1' ' A' ' 12' ' ' DBB . 99.1 mm-40 -74.17 -2.6 25.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.541 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' DBB . . . . . 0.708 ' H ' ' HG2' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.621 ' HA3' ' C ' ' A' ' 5' ' ' DBU . . . -28.01 148.63 0.01 OUTLIER Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.8 p -149.31 -17.96 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.853 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.54 ' HB3' ' O ' ' A' ' 13' ' ' DAL . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.622 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.4 mmt85 -64.61 -41.5 96.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.833 0.349 . . . . 0.0 110.629 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.627 HG22 ' HA ' ' A' ' 7' ' ' PRO . 84.8 mt -72.29 -4.6 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.75 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 99.2 m-20 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.377 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.427 ' O ' HG23 ' A' ' 3' ' ' ILE . 9.5 p . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.848 0.356 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.627 ' HA ' HG22 ' A' ' 3' ' ' ILE . 49.1 Cg_endo -72.09 43.42 0.59 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.692 2.261 . . . . 0.0 111.878 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -114.11 -30.58 6.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.428 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.408 ' O ' HG12 ' A' ' 3' ' ' ILE . . . -167.86 161.1 34.87 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.613 ' HA2' HD11 ' A' ' 3' ' ' ILE . . . -64.69 -31.75 81.95 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.393 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.657 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.633 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 78.9 mm-40 . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 120.746 0.308 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 . . . . . 0 C--N 1.332 -0.18 0 CA-C-O 120.896 0.379 . . . . 0.0 110.417 179.779 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.633 ' SG ' ' N ' ' A' ' 14' ' ' GLU . 12.6 p . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.461 0.172 . . . . 0.0 111.315 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.313 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.574 ' O ' ' OD1' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.518 ' HB3' ' HA2' ' A' ' 10' ' ' GLY . 84.3 mtp180 -61.95 -36.2 80.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.832 0.348 . . . . 0.0 110.594 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.811 HD13 ' H ' ' A' ' 4' ' ' ASP . 0.2 OUTLIER -52.7 -36.66 23.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.516 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.811 ' H ' HD13 ' A' ' 3' ' ' ILE . 90.1 m-20 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.629 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 3' ' ' ILE . 22.5 p . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.793 0.33 . . . . 0.0 110.572 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -78.5 18.33 0.97 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.918 2.412 . . . . 0.0 112.175 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -85.92 -42.38 14.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.614 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.4 171.99 44.28 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.518 ' HA2' ' HB3' ' A' ' 2' ' ' ARG . . . -60.62 -43.14 99.31 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.638 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.827 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 20' ' ' CYS . 22.5 pt-20 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.874 0.368 . . . . 0.0 110.552 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.582 179.949 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 1.6 p . . . . . 0 N--CA 1.457 -0.08 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.621 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.849 -1.072 . . . . 0.0 110.564 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -63.86 -42.0 97.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.959 0.409 . . . . 0.0 110.825 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.699 HD11 ' HA2' ' A' ' 10' ' ' GLY . 41.0 mm -61.18 -23.93 31.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.482 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.532 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 98.1 m-20 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.317 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.968 0.413 . . . . 0.0 110.577 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.641 ' HA ' HG23 ' A' ' 3' ' ' ILE . 53.2 Cg_endo -73.4 39.65 0.49 Allowed 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 122.77 2.313 . . . . 0.0 112.01 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -109.0 -31.74 7.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.47 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.72 158.85 31.89 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.699 ' HA2' HD11 ' A' ' 3' ' ' ILE . . . -62.87 -30.27 76.69 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.627 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.746 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.679 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 80.5 tt0 . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.779 0.323 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.4 179.916 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.679 ' SG ' ' N ' ' A' ' 14' ' ' GLU . 15.3 p . . . . . 0 CA--C 1.527 0.095 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.533 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -59.48 -34.69 72.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.949 0.404 . . . . 0.0 110.302 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 3' ' ' ILE . 33.1 mm -63.02 -42.23 95.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.262 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 . . . . . 0 C--N 1.331 -0.214 0 CA-C-O 120.963 0.411 . . . . 0.0 110.572 -179.481 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.667 ' SG ' ' HD2' ' A' ' 7' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.134 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.697 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 36.1 Cg_exo -56.96 -25.69 63.96 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.748 2.299 . . . . 0.0 111.92 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 7' ' ' PRO . . . 99.05 43.17 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.403 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.23 31.93 6.92 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.97 -63.16 2.04 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.458 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.5 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.608 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 97.4 mt-10 . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.936 0.398 . . . . 0.0 110.288 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.265 179.333 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' A' ' 14' ' ' GLU . 15.4 p . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.714 0.293 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.427 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.571 ' N ' ' OD1' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.562 ' HB3' ' CA ' ' A' ' 10' ' ' GLY . 90.3 mtm-85 -64.38 -37.96 89.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 110.68 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.6 ' O ' ' N ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -67.26 -23.15 29.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.552 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 1' ' ' GLY . 98.8 m-20 . . . . . 0 N--CA 1.462 0.151 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.09 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.667 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.112 0 CA-C-O 121.165 0.507 . . . . 0.0 110.341 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.515 ' HA ' ' HB ' ' A' ' 3' ' ' ILE . 58.5 Cg_endo -80.06 12.58 2.43 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 123.057 2.504 . . . . 0.0 112.03 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.2 -11.69 37.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.622 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 3' ' ' ILE . . . 172.14 170.41 35.99 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.562 ' CA ' ' HB3' ' A' ' 2' ' ' ARG . . . -64.02 -39.7 97.49 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.394 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.802 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 . . . . . 0 N--CA 1.456 -0.138 0 CA-C-O 120.944 0.402 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 . . . . . 0 C--N 1.331 -0.218 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.643 179.554 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 10.0 p . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.763 0.316 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.54 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.589 ' CG ' ' O ' ' A' ' 10' ' ' GLY . 0.6 OUTLIER -69.17 -22.92 63.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.881 0.372 . . . . 0.0 110.702 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.56 ' CG2' ' HA ' ' A' ' 7' ' ' PRO . 5.1 mm -105.99 3.24 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.446 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 67.4 t0 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.373 179.957 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.543 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 30.3 p . . . . . 0 CA--C 1.522 -0.123 0 CA-C-O 120.869 0.366 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.56 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 38.1 Cg_endo -69.88 23.41 0.18 Allowed 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.719 2.279 . . . . 0.0 111.961 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.484 ' H ' ' C ' ' A' ' 6' ' ' CYS . . . -89.13 -41.97 11.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.764 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.58 162.13 31.8 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.589 ' O ' ' CG ' ' A' ' 2' ' ' ARG . . . -64.03 -32.4 84.05 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.57 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -179.568 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.839 0.352 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.584 179.861 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 10.4 p . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.771 0.32 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.653 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.543 ' O ' ' CG ' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -61.44 -22.92 65.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.913 0.387 . . . . 0.0 110.57 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.835 HG23 ' HB2' ' A' ' 8' ' ' ALA . 90.5 mt -62.95 -42.79 97.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.495 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.543 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 51.1 p30 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.568 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.661 ' SG ' ' HD2' ' A' ' 7' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.102 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.733 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 32.8 Cg_exo -56.25 -23.47 45.83 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.862 2.375 . . . . 0.0 112.151 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.835 ' HB2' HG23 ' A' ' 3' ' ' ILE . . . 94.45 44.22 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.469 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.68 33.12 6.48 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.55 -61.35 1.96 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.631 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.93 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.642 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 68.9 mm-40 . . . . . 0 N--CA 1.461 0.082 0 CA-C-O 120.907 0.384 . . . . 0.0 110.756 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.77 179.55 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.575 ' O ' ' C ' ' A' ' 20' ' ' CYS . 18.2 p . . . . . 0 CA--C 1.527 0.082 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.642 ' SG ' ' O ' ' A' ' 14' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.047 -0.978 . . . . 0.0 111.079 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -62.49 -43.56 98.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.784 0.326 . . . . 0.0 110.563 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.525 HG22 ' O ' ' A' ' 3' ' ' ILE . 71.4 mt -81.31 -7.67 10.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.508 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' A' ' 1' ' ' GLY . 65.1 t0 . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.347 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.442 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 26.4 p . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 121.044 0.449 . . . . 0.0 110.418 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.491 ' HA ' HG22 ' A' ' 3' ' ' ILE . 42.0 Cg_endo -70.82 42.44 0.41 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.823 2.349 . . . . 0.0 111.961 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -114.99 -29.15 6.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.584 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.64 158.62 31.65 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.99 -31.21 80.18 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.622 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.744 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.432 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 58.3 mp0 . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.848 0.356 . . . . 0.0 110.494 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.465 179.92 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 12.2 p . . . . . 0 N--CA 1.457 -0.075 0 CA-C-O 120.617 0.246 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.568 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.606 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -63.88 -38.78 92.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.786 0.327 . . . . 0.0 110.633 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 95.9 mt -66.21 -24.62 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.544 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 63.7 t0 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.532 179.9 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.672 ' SG ' ' HD2' ' A' ' 7' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.88 0.371 . . . . 0.0 110.537 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.686 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 32.6 Cg_exo -57.51 -26.29 71.01 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.929 2.419 . . . . 0.0 111.975 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.686 ' HB3' ' O ' ' A' ' 7' ' ' PRO . . . 102.33 55.92 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.665 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -115.06 24.96 10.32 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.63 -59.08 1.66 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.477 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 179.587 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.665 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 17.7 pt-20 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.904 0.383 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.517 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 80.9 mt-30 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.565 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.665 ' SG ' ' N ' ' A' ' 14' ' ' GLU . 13.5 p . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.937 0.399 . . . . 0.0 110.738 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.846 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.371 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.511 ' O ' ' HB ' ' A' ' 3' ' ' ILE . 90.3 mtm-85 -67.42 146.9 53.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.804 0.335 . . . . 0.0 110.424 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 6' ' ' CYS . 43.3 mm 73.06 -16.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.638 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.464 ' H ' ' C ' ' A' ' 2' ' ' ARG . 43.9 t0 . . . . . 0 C--N 1.332 -0.173 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.39 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.691 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.072 0 CA-C-O 121.24 0.543 . . . . 0.0 110.404 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.418 ' HA ' HG23 ' A' ' 3' ' ' ILE . 55.4 Cg_endo -73.73 -9.17 22.32 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.8 2.334 . . . . 0.0 111.325 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.97 -38.21 90.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.436 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.409 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . -174.41 157.06 24.39 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.717 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.99 -23.81 40.25 Favored Glycine 0 C--N 1.331 0.303 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.394 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 178.697 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 120.777 0.322 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.479 -179.951 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 1.7 p . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.458 0.17 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.402 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--O 1.221 -0.423 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.441 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.772 ' O ' HD12 ' A' ' 3' ' ' ILE . 90.5 mtm-85 -70.1 146.17 51.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 0.0 110.67 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.772 HD12 ' O ' ' A' ' 2' ' ' ARG . 1.2 mp 73.01 -5.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.593 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.522 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 55.1 m-20 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.35 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.754 0.311 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.501 ' HA ' HG23 ' A' ' 3' ' ' ILE . 39.4 Cg_endo -69.46 6.89 1.04 Allowed 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.753 2.302 . . . . 0.0 112.109 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.39 -37.89 89.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.587 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.0 -171.47 43.43 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.16 160.79 26.4 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.654 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 -179.532 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.653 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 47.6 mt-10 . . . . . 0 N--CA 1.461 0.103 0 CA-C-O 120.878 0.371 . . . . 0.0 110.499 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.305 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.644 ' SG ' ' O ' ' A' ' 19' ' ' CYS . 9.7 p . . . . . 0 N--CA 1.463 0.178 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.653 ' SG ' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.561 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -61.88 -43.07 99.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.768 0.318 . . . . 0.0 110.611 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.552 HD13 ' N ' ' A' ' 4' ' ' ASP . 0.1 OUTLIER -72.26 -14.73 17.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.344 -179.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.552 ' N ' HD13 ' A' ' 3' ' ' ILE . 4.6 t0 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.416 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.531 ' O ' ' HB ' ' A' ' 3' ' ' ILE . 1.4 p . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.897 0.38 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.515 ' HA ' ' HB ' ' A' ' 3' ' ' ILE . 39.1 Cg_endo -69.98 18.25 0.2 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.936 2.424 . . . . 0.0 112.149 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.505 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -107.92 -74.09 0.67 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.755 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.562 ' O ' ' C ' ' A' ' 10' ' ' GLY . . . -176.13 172.66 45.65 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.562 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . -27.41 -52.93 0.09 OUTLIER Glycine 0 CA--C 1.518 0.239 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.531 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.68 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 17.6 pt-20 . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 120.644 0.259 . . . . 0.0 110.714 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.785 -179.999 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.619 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 3.0 p . . . . . 0 CA--C 1.531 0.246 0 CA-C-O 120.591 0.234 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.221 -0.413 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.835 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 89.2 mtm-85 -61.13 -41.6 97.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.748 0.309 . . . . 0.0 110.563 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.823 ' C ' HD13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -94.21 -5.22 10.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.458 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 67.2 t0 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.498 -179.593 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.658 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.814 0.34 . . . . 0.0 110.404 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.13 43.36 1.52 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.761 2.307 . . . . 0.0 112.19 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -121.01 -34.83 3.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.526 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.84 -178.7 47.57 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.48 -40.8 99.19 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.57 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.934 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 . . . . . 0 N--CA 1.455 -0.197 0 CA-C-O 120.799 0.333 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 179.775 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.597 ' O ' ' C ' ' A' ' 20' ' ' CYS . 17.5 p . . . . . 0 N--CA 1.456 -0.131 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.597 ' C ' ' O ' ' A' ' 19' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 117.97 -1.015 . . . . 0.0 110.681 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.555 ' HG3' ' CA ' ' A' ' 10' ' ' GLY . 23.8 tpt180 -61.96 -42.78 99.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.294 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.533 ' H ' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -75.37 -15.32 15.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.846 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 3' ' ' ILE . 68.2 t0 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.832 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.654 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 121.185 0.517 . . . . 0.0 109.921 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -84.02 42.94 1.29 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 123.117 2.544 . . . . 0.0 112.381 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.501 ' CB ' ' OE1' ' A' ' 15' ' ' GLN . . . -126.7 -33.06 2.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.681 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.35 172.2 45.01 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.555 ' CA ' ' HG3' ' A' ' 2' ' ' ARG . . . -64.93 -38.32 95.36 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.461 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . . . . . . 0 CA--C 1.523 0.537 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.732 0.301 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.501 ' OE1' ' CB ' ' A' ' 8' ' ' ALA . 79.6 mt-30 . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.553 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.148 0 CA-C-O 120.979 0.419 . . . . 0.0 109.908 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.639 179.874 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.44 ' HA3' ' CB ' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.493 2.449 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -59.3 -42.79 92.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.981 0.42 . . . . 0.0 110.162 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.533 ' O ' ' O ' ' A' ' 6' ' ' CYS . 5.7 pt -102.07 -0.44 10.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.967 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.44 ' CB ' ' HA3' ' A' ' 1' ' ' GLY . 65.1 t0 . . . . . 0 C--N 1.333 -0.147 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.021 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.623 ' SG ' ' HD2' ' A' ' 7' ' ' PRO . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 120.909 0.385 . . . . 0.0 110.255 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.693 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 31.7 Cg_exo -57.56 -25.74 68.67 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 123.147 2.565 . . . . 0.0 112.239 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' A' ' 7' ' ' PRO . . . 100.05 46.85 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.902 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.98 20.9 48.98 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.79 -58.1 3.86 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.168 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 178.719 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.641 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 49.8 tp10 . . . . . 0 N--CA 1.455 -0.207 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.525 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 48.2 mt-30 . . . . . 0 N--CA 1.455 -0.194 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.402 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.552 ' SG ' ' N ' ' A' ' 14' ' ' GLU . 9.6 p . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.896 0.379 . . . . 0.0 110.522 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.641 ' SG ' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.497 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -64.01 -37.57 87.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.752 0.31 . . . . 0.0 110.463 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.592 HG13 ' N ' ' A' ' 6' ' ' CYS . 0.7 OUTLIER -100.04 1.54 10.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.09 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 3' ' ' ILE . 99.0 m-20 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.391 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.642 ' SG ' ' O ' ' A' ' 9' ' ' GLY . 1.6 p . . . . . 0 CA--C 1.529 0.146 0 CA-C-O 120.907 0.384 . . . . 0.0 110.017 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.479 ' HA ' ' HB ' ' A' ' 3' ' ' ILE . 45.9 Cg_endo -69.69 54.72 1.18 Allowed 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 123.217 2.612 . . . . 0.0 113.332 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.625 ' HB3' ' HB3' ' A' ' 15' ' ' GLN . . . -158.41 -36.81 0.07 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.8 0.333 . . . . 0.0 110.496 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.642 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . 158.71 -168.23 34.86 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.46 170.55 26.8 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.595 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . . . . . . 0 CA--C 1.52 0.348 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 . . . . . 0 CA--C 1.522 -0.104 0 CA-C-O 120.981 0.42 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.625 ' HB3' ' HB3' ' A' ' 8' ' ' ALA . 77.8 mt-30 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.826 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.595 ' SG ' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.8 0.333 . . . . 0.0 110.237 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 19' ' ' CYS . 1.5 m . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.632 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -63.37 -41.02 98.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 110.701 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.583 HG22 ' O ' ' A' ' 3' ' ' ILE . 49.3 mm -77.17 -0.98 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.501 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 45.6 t0 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.539 -179.656 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.592 ' SG ' ' HD2' ' A' ' 7' ' ' PRO . 4.9 t . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.936 0.398 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.736 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 52.6 Cg_exo -51.63 -8.57 0.28 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.874 2.382 . . . . 0.0 112.181 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 7' ' ' PRO . . . 91.37 28.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.496 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.64 16.79 55.61 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.27 -54.99 1.52 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.498 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.566 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.603 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 58.1 mp0 . . . . . 0 N--CA 1.455 -0.201 0 CA-C-O 120.856 0.36 . . . . 0.0 110.705 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.564 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 92.3 mm-40 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.044 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.641 ' SG ' ' O ' ' A' ' 19' ' ' CYS . 0.8 OUTLIER . . . . . 0 CA--C 1.519 -0.222 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.647 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.218 -0.556 0 CA-C-O 117.91 -1.043 . . . . 0.0 110.787 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.556 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 80.3 mtp85 -67.27 145.34 55.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.813 0.339 . . . . 0.0 110.572 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 6' ' ' CYS . 30.5 mm 73.4 -16.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.561 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' A' ' 2' ' ' ARG . 67.3 t0 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.568 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.687 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.857 0.36 . . . . 0.0 110.488 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.99 -2.83 13.1 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.846 2.364 . . . . 0.0 112.14 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.02 -39.69 72.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.578 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.521 ' O ' HD13 ' A' ' 3' ' ' ILE . . . -165.59 165.04 37.7 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.556 ' O ' ' CB ' ' A' ' 2' ' ' ARG . . . -63.54 -35.04 91.51 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.662 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.775 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.452 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 59.8 mp0 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.823 0.344 . . . . 0.0 110.581 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.606 179.957 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.409 0.147 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.221 -0.423 0 CA-C-O 117.865 -1.064 . . . . 0.0 110.466 -179.985 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -62.58 -43.19 99.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.825 0.345 . . . . 0.0 110.615 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.523 ' CG1' ' HA2' ' A' ' 10' ' ' GLY . 6.1 mt -57.44 -16.2 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.428 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 65.2 t0 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.283 -179.808 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.687 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 121.053 0.454 . . . . 0.0 110.092 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.91 14.99 1.38 Allowed 'Trans proline' 0 C--N 1.304 -1.816 0 C-N-CA 122.855 2.37 . . . . 0.0 112.014 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.63 -51.94 6.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.616 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.52 ' C ' HG12 ' A' ' 3' ' ' ILE . . . 172.1 168.72 33.96 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.523 ' HA2' ' CG1' ' A' ' 3' ' ' ILE . . . -41.78 -23.51 0.13 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 9' ' ' GLY . . . . . . . . 0 CA--C 1.52 0.393 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 120.808 0.337 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.566 179.926 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 18.8 p . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.646 0.26 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.617 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--O 1.219 -0.526 0 CA-C-O 117.924 -1.036 . . . . 0.0 110.612 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.596 ' NH2' ' O ' ' A' ' 10' ' ' GLY . 79.6 mtp85 -62.57 140.07 58.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.809 0.338 . . . . 0.0 110.543 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.565 ' HB ' ' O ' ' A' ' 2' ' ' ARG . 50.6 mm 73.38 -27.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.534 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 56.4 m-20 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.568 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.695 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 121.115 0.483 . . . . 0.0 110.217 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.436 ' HA ' HG23 ' A' ' 3' ' ' ILE . 55.6 Cg_endo -75.39 -8.48 19.65 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.845 2.364 . . . . 0.0 112.093 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.01 -38.73 91.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.579 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.16 163.52 36.88 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.596 ' O ' ' NH2' ' A' ' 2' ' ' ARG . . . -63.32 -33.7 87.97 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.76 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.894 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.481 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 56.5 mp0 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.81 0.338 . . . . 0.0 110.604 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.541 -179.951 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.8 p . . . . . 0 CA--C 1.532 0.271 0 N-CA-C 110.853 -0.055 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.622 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.904 ' O ' ' HG3' ' A' ' 18' ' ' DBU . 28.4 mmt85 -64.61 -41.5 96.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.833 0.349 . . . . 0.0 110.629 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.627 HG22 ' HA ' ' A' ' 7' ' ' PRO . 84.8 mt -72.29 -4.6 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.75 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 99.2 m-20 -62.12 -42.41 99.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.377 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.691 ' HB3' ' C ' ' A' ' 16' ' ' DBB . 9.5 p -140.51 82.6 15.98 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.857 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.627 ' HA ' HG22 ' A' ' 3' ' ' ILE . 49.1 Cg_endo -72.09 43.42 0.59 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.692 2.261 . . . . 0.0 111.878 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -114.11 -30.58 6.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.428 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.408 ' O ' HG12 ' A' ' 3' ' ' ILE . . . -167.86 161.1 34.87 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.613 ' HA2' HD11 ' A' ' 3' ' ' ILE . . . -64.69 -31.75 81.95 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -55.18 -44.46 83.96 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' DBB . . . . . 0.832 ' HG2' ' HB2' ' A' ' 15' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' DAL . . . . . 0.611 ' C ' ' N ' ' A' ' 15' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.625 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 78.9 mm-40 -41.63 -17.88 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.448 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.832 ' HB2' ' HG2' ' A' ' 12' ' ' DBB . 98.5 mm-40 -53.96 -8.92 0.21 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.896 0.379 . . . . 0.0 110.417 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' DBB . . . . . 0.691 ' C ' ' HB3' ' A' ' 6' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.66 ' O ' ' C ' ' A' ' 18' ' ' DBU . . . 10.79 -123.49 0.01 OUTLIER Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' DBU . . . . . 0.904 ' HG3' ' O ' ' A' ' 2' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.625 ' SG ' ' N ' ' A' ' 14' ' ' GLU . 12.6 p -103.76 -12.13 17.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.315 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.568 ' HB3' ' C ' ' A' ' 16' ' ' DBB . 0.1 OUTLIER . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.313 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.574 ' O ' ' OD1' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.518 ' HB3' ' HA2' ' A' ' 10' ' ' GLY . 84.3 mtp180 -61.95 -36.2 80.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.832 0.348 . . . . 0.0 110.594 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.811 HD13 ' H ' ' A' ' 4' ' ' ASP . 0.2 OUTLIER -52.7 -36.66 23.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.516 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.811 ' H ' HD13 ' A' ' 3' ' ' ILE . 90.1 m-20 32.15 56.19 0.35 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.629 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' DBU . . . . . 0.518 ' O ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 1.213 ' SG ' ' HG2' ' A' ' 18' ' ' DBU . 22.5 p -68.04 109.2 3.55 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.572 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 5' ' ' DBU . 56.9 Cg_endo -78.5 18.33 0.97 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.918 2.412 . . . . 0.0 112.175 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -85.92 -42.38 14.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.614 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.4 171.99 44.28 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.518 ' HA2' ' HB3' ' A' ' 2' ' ' ARG . . . -60.62 -43.14 99.31 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -43.16 -72.54 0.31 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' DBB . . . . . 0.609 ' CG ' ' H ' ' A' ' 16' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' DAL . . . . . 0.606 ' C ' ' H ' ' A' ' 15' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 20' ' ' CYS . 22.5 pt-20 -53.51 -6.67 0.08 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.874 0.368 . . . . 0.0 110.552 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.606 ' H ' ' C ' ' A' ' 13' ' ' DAL . 76.4 mt-30 -54.97 -39.53 69.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.582 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' DBB . . . . . 0.641 ' O ' ' C ' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.749 ' O ' ' C ' ' A' ' 18' ' ' DBU . . . -10.35 -107.17 0.0 OUTLIER Glycine 0 CA--C 1.522 0.477 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' DBU . . . . . 1.213 ' HG2' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.616 ' N ' ' O ' ' A' ' 17' ' ' GLY . 1.6 p -118.95 -35.96 3.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.534 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.621 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.849 -1.072 . . . . 0.0 110.564 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.829 ' O ' ' HG3' ' A' ' 18' ' ' DBU . 99.4 mtt180 -63.86 -42.0 97.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.959 0.409 . . . . 0.0 110.825 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.699 HD11 ' HA2' ' A' ' 10' ' ' GLY . 41.0 mm -61.18 -23.93 31.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.482 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.8 ' O ' ' HG2' ' A' ' 5' ' ' DBU . 98.1 m-20 -57.74 81.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.317 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' DBU . . . . . 0.8 ' HG2' ' O ' ' A' ' 4' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.697 ' HB3' ' C ' ' A' ' 16' ' ' DBB . 9.0 p -128.99 83.54 65.88 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.577 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.641 ' HA ' HG23 ' A' ' 3' ' ' ILE . 53.2 Cg_endo -73.4 39.65 0.49 Allowed 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 122.77 2.313 . . . . 0.0 112.01 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -109.0 -31.74 7.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.47 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.72 158.85 31.89 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.699 ' HA2' HD11 ' A' ' 3' ' ' ILE . . . -62.87 -30.27 76.69 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.57 -44.36 93.89 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' DBB . . . . . 0.96 ' HA ' ' HG2' ' A' ' 18' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' DAL . . . . . 0.785 ' HB3' ' H ' ' A' ' 19' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.673 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 80.5 tt0 -39.3 -20.87 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.617 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.842 ' HB2' ' HG2' ' A' ' 12' ' ' DBB . 99.7 mm-40 -53.65 -9.57 0.22 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.4 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' DBB . . . . . 0.697 ' C ' ' HB3' ' A' ' 6' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.676 ' O ' ' C ' ' A' ' 18' ' ' DBU . . . 11.97 -126.44 0.01 OUTLIER Glycine 0 CA--C 1.521 0.429 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' DBU . . . . . 0.96 ' HG2' ' HA ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.785 ' H ' ' HB3' ' A' ' 13' ' ' DAL . 15.3 p -96.54 -12.98 23.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.583 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.577 ' HB3' ' C ' ' A' ' 16' ' ' DBB . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.533 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.898 ' O ' ' HG3' ' A' ' 18' ' ' DBU . 94.2 mtt-85 -59.48 -34.69 72.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.949 0.404 . . . . 0.0 110.302 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 3' ' ' ILE . 33.1 mm -63.02 -42.23 95.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.262 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -59.56 140.31 56.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.963 0.411 . . . . 0.0 110.572 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' DBU . . . . . 0.689 ' O ' ' HG2' ' A' ' 16' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.686 ' SG ' ' C ' ' A' ' 16' ' ' DBB . 0.5 OUTLIER -97.34 155.6 37.18 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.187 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.697 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 36.1 Cg_exo -56.96 -25.69 63.96 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.748 2.299 . . . . 0.0 111.92 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 7' ' ' PRO . . . 99.05 43.17 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.403 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.23 31.93 6.92 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.97 -63.16 2.04 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.469 ' C ' ' N ' ' A' ' 13' ' ' DAL . . . -63.26 -39.38 97.8 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' DBB . . . . . 0.906 ' HA ' ' HG2' ' A' ' 18' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' DAL . . . . . 0.677 ' HB3' ' H ' ' A' ' 19' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.608 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 97.4 mt-10 -39.64 -20.55 0.01 OUTLIER 'General case' 0 C--N 1.341 0.233 0 CA-C-O 120.936 0.398 . . . . 0.0 110.288 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.822 ' HB2' ' HG3' ' A' ' 12' ' ' DBB . 84.1 mt-30 -54.52 -8.92 0.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.265 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' DBB . . . . . 0.689 ' HG2' ' O ' ' A' ' 5' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.635 ' O ' ' C ' ' A' ' 18' ' ' DBU . . . 9.57 -118.45 0.01 OUTLIER Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' DBU . . . . . 0.906 ' HG2' ' HA ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.677 ' H ' ' HB3' ' A' ' 13' ' ' DAL . 15.4 p -116.19 -10.55 11.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.978 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.594 ' N ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.427 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.571 ' N ' ' OD1' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.571 ' O ' ' HG1' ' A' ' 18' ' ' DBU . 90.3 mtm-85 -64.38 -37.96 89.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 110.68 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.6 ' O ' ' N ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -67.26 -23.15 29.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.552 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 1.114 ' O ' ' HG3' ' A' ' 18' ' ' DBU . 98.8 m-20 -21.75 113.49 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.09 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' DBU . . . . . 0.618 ' C ' ' HA3' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.667 ' SG ' ' O ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -104.25 96.97 10.67 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.341 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 5' ' ' DBU . 58.5 Cg_endo -80.06 12.58 2.43 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 123.057 2.504 . . . . 0.0 112.03 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.2 -11.69 37.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.622 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 3' ' ' ILE . . . 172.14 170.41 35.99 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.562 ' CA ' ' HB3' ' A' ' 2' ' ' ARG . . . -64.02 -39.7 97.49 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.7 -76.09 0.27 Allowed Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' DBB . . . . . 0.75 ' HG2' ' H ' ' A' ' 16' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' DAL . . . . . 0.517 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -72.86 -4.05 29.38 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 120.499 -0.48 . . . . 0.0 109.973 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.688 ' C ' ' HG1' ' A' ' 12' ' ' DBB . 89.2 mt-30 -71.15 -6.96 43.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.643 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' DBB . . . . . 0.75 ' H ' ' HG2' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.618 ' HA3' ' C ' ' A' ' 5' ' ' DBU . . . -32.7 162.24 0.0 OUTLIER Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.762 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' DBU . . . . . 1.114 ' HG3' ' O ' ' A' ' 4' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' A' ' 13' ' ' DAL . 10.0 p -136.97 3.63 2.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.728 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.68 ' HB2' ' C ' ' A' ' 16' ' ' DBB . 0.8 OUTLIER . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.54 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.878 ' HA ' ' HG1' ' A' ' 18' ' ' DBU . 0.6 OUTLIER -69.17 -22.92 63.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.881 0.372 . . . . 0.0 110.702 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.56 ' CG2' ' HA ' ' A' ' 7' ' ' PRO . 5.1 mm -105.99 3.24 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.446 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -85.09 106.65 16.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.373 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' DBU . . . . . 0.51 ' CA ' ' HA3' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.648 ' SG ' ' O ' ' A' ' 17' ' ' GLY . 30.3 p -150.86 78.65 7.33 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.916 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.56 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 38.1 Cg_endo -69.88 23.41 0.18 Allowed 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.719 2.279 . . . . 0.0 111.961 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.484 ' H ' ' C ' ' A' ' 6' ' ' CYS . . . -89.13 -41.97 11.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.764 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.58 162.13 31.8 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.589 ' O ' ' CG ' ' A' ' 2' ' ' ARG . . . -64.03 -32.4 84.05 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -53.7 -43.37 69.08 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' DBB . . . . . 0.683 ' HG2' ' HB2' ' A' ' 15' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' DAL . . . . . 0.513 ' HB3' ' O ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.404 ' C ' ' N ' ' A' ' 16' ' ' DBB . 45.0 mt-10 -59.19 -17.12 24.76 Favored 'General case' 0 C--O 1.232 0.165 0 O-C-N 122.054 -0.404 . . . . 0.0 110.581 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.683 ' HB2' ' HG2' ' A' ' 12' ' ' DBB . 84.6 mt-30 -57.14 -6.57 0.4 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.584 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' DBB . . . . . 0.562 ' O ' ' O ' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.648 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . -28.04 149.6 0.01 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' DBU . . . . . 0.878 ' HG1' ' HA ' ' A' ' 2' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 10.4 p -133.73 -20.84 1.99 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.06 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.488 ' HB3' ' O ' ' A' ' 16' ' ' DBB . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.653 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.543 ' O ' ' CG ' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.532 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 95.0 mtt180 -61.44 -22.92 65.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.913 0.387 . . . . 0.0 110.57 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.835 HG23 ' HB2' ' A' ' 8' ' ' ALA . 90.5 mt -62.95 -42.79 97.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.495 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 5' ' ' DBU . 51.1 p30 -43.8 -20.85 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.568 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' DBU . . . . . 0.654 ' C ' ' H ' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.692 ' SG ' ' C ' ' A' ' 16' ' ' DBB . 0.5 OUTLIER -86.69 154.25 55.87 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.102 179.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.733 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 32.8 Cg_exo -56.25 -23.47 45.83 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.862 2.375 . . . . 0.0 112.151 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.835 ' HB2' HG23 ' A' ' 3' ' ' ILE . . . 94.45 44.22 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.469 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.68 33.12 6.48 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.55 -61.35 1.96 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.406 ' C ' ' N ' ' A' ' 13' ' ' DAL . . . -64.42 -38.74 96.2 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' DBB . . . . . 0.915 ' HA ' ' HG2' ' A' ' 18' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' DAL . . . . . 0.747 ' HB3' ' H ' ' A' ' 19' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.642 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 68.9 mm-40 -38.57 -21.36 0.01 OUTLIER 'General case' 0 C--N 1.34 0.181 0 CA-C-O 120.907 0.384 . . . . 0.0 110.756 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.869 ' HB2' ' HG3' ' A' ' 12' ' ' DBB . 40.7 mt-30 -50.94 -24.61 3.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.77 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' DBB . . . . . 0.723 ' C ' ' HB2' ' A' ' 20' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.664 ' O ' ' C ' ' A' ' 18' ' ' DBU . . . 6.56 -119.69 0.01 OUTLIER Glycine 0 N--CA 1.463 0.486 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' DBU . . . . . 0.915 ' HG2' ' HA ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.747 ' H ' ' HB3' ' A' ' 13' ' ' DAL . 18.2 p -105.33 -21.41 13.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.186 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.723 ' HB2' ' C ' ' A' ' 16' ' ' DBB . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.047 -0.978 . . . . 0.0 111.079 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.661 ' O ' ' HG3' ' A' ' 18' ' ' DBU . 83.8 mtt85 -62.49 -43.56 98.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.784 0.326 . . . . 0.0 110.563 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.525 ' O ' HG22 ' A' ' 3' ' ' ILE . 71.4 mt -81.31 -7.67 10.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.508 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' A' ' 1' ' ' GLY . 65.1 t0 -61.75 -42.65 99.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.347 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.67 ' SG ' ' O ' ' A' ' 17' ' ' GLY . 26.4 p -125.71 78.16 69.22 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.418 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.491 ' HA ' HG22 ' A' ' 3' ' ' ILE . 42.0 Cg_endo -70.82 42.44 0.41 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.823 2.349 . . . . 0.0 111.961 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -114.99 -29.15 6.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.584 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.64 158.62 31.65 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.99 -31.21 80.18 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -54.7 -42.82 79.02 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' DBB . . . . . 0.67 ' HG2' ' HB2' ' A' ' 15' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' DAL . . . . . 0.476 ' HB3' ' O ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.401 ' C ' ' N ' ' A' ' 16' ' ' DBB . 58.3 mp0 -60.64 -16.52 39.55 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.848 0.356 . . . . 0.0 110.494 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.67 ' HB2' ' HG2' ' A' ' 12' ' ' DBB . 85.3 mt-30 -58.79 -4.12 0.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.465 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' DBB . . . . . 0.554 ' C ' ' HB3' ' A' ' 6' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.67 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . -28.15 148.53 0.01 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' DBU . . . . . 0.661 ' HG3' ' O ' ' A' ' 2' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 12.2 p -135.1 -10.75 2.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.944 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.568 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.606 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.492 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 83.4 mtp180 -63.88 -38.78 92.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.786 0.327 . . . . 0.0 110.633 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 95.9 mt -66.21 -24.62 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.544 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -62.71 -41.48 99.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.532 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.746 ' SG ' ' C ' ' A' ' 16' ' ' DBB . 0.1 OUTLIER -75.95 158.73 82.07 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.537 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.686 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 32.6 Cg_exo -57.51 -26.29 71.01 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.929 2.419 . . . . 0.0 111.975 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.686 ' HB3' ' O ' ' A' ' 7' ' ' PRO . . . 102.33 55.92 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.665 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -115.06 24.96 10.32 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.63 -59.08 1.66 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 13' ' ' DAL . . . -62.77 -33.95 88.33 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' DBB . . . . . 0.866 ' HG3' ' HB2' ' A' ' 15' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' DAL . . . . . 0.614 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.665 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 17.7 pt-20 -37.65 -22.97 0.01 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.904 0.383 . . . . 0.0 110.257 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.866 ' HB2' ' HG3' ' A' ' 12' ' ' DBB . 80.9 mt-30 -54.65 -7.9 0.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.565 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' DBB . . . . . 0.746 ' C ' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.623 ' O ' ' O ' ' A' ' 12' ' ' DBB . . . -35.83 132.53 0.72 Allowed Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' DBU . . . . . 0.738 ' HG2' ' HA ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.665 ' SG ' ' N ' ' A' ' 14' ' ' GLU . 13.5 p -140.8 8.56 2.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.738 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.846 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.371 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.627 ' HA ' ' HG1' ' A' ' 18' ' ' DBU . 90.3 mtm-85 -67.42 146.9 53.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.804 0.335 . . . . 0.0 110.424 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 6' ' ' CYS . 43.3 mm 73.06 -16.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.638 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.464 ' H ' ' C ' ' A' ' 2' ' ' ARG . 43.9 t0 -63.52 -40.56 97.37 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.39 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' DBU . . . . . 0.61 ' C ' ' HA3' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.691 ' SG ' ' O ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -111.12 88.38 8.41 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.404 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.418 ' HA ' HG23 ' A' ' 3' ' ' ILE . 55.4 Cg_endo -73.73 -9.17 22.32 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.8 2.334 . . . . 0.0 111.325 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.97 -38.21 90.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.436 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.409 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . -174.41 157.06 24.39 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.717 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.99 -23.81 40.25 Favored Glycine 0 C--N 1.331 0.303 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 13' ' ' DAL . . . -87.22 51.74 4.27 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' DBB . . . . . 0.681 ' CG ' ' H ' ' A' ' 16' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' DAL . . . . . 0.57 ' N ' ' O ' ' A' ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -75.0 -5.03 41.79 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.405 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.657 ' C ' ' HG1' ' A' ' 12' ' ' DBB . 86.3 mt-30 -72.86 -8.04 53.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.479 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' DBB . . . . . 0.681 ' H ' ' CG ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.61 ' HA3' ' C ' ' A' ' 5' ' ' DBU . . . -31.68 156.71 0.0 OUTLIER Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' DBU . . . . . 0.627 ' HG1' ' HA ' ' A' ' 2' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 1.7 p -156.65 -31.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.039 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.54 ' HB3' ' O ' ' A' ' 13' ' ' DAL . 0.5 OUTLIER . . . . . 0 C--O 1.221 -0.423 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.441 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.772 ' O ' HD12 ' A' ' 3' ' ' ILE . 90.5 mtm-85 -70.1 146.17 51.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 0.0 110.67 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.772 HD12 ' O ' ' A' ' 2' ' ' ARG . 1.2 mp 73.01 -5.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.593 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.522 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 55.1 m-20 -61.71 -39.87 93.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.35 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' DBU . . . . . 0.673 ' C ' ' H ' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.682 ' SG ' ' N ' ' A' ' 16' ' ' DBB . 7.8 t -117.92 57.89 2.71 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.273 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.562 ' HD3' ' C ' ' A' ' 5' ' ' DBU . 39.4 Cg_endo -69.46 6.89 1.04 Allowed 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.753 2.302 . . . . 0.0 112.109 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.39 -37.89 89.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.587 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.0 -171.47 43.43 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.408 ' C ' ' H1 ' ' A' ' 12' ' ' DBB . . . -61.16 160.79 26.4 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.613 ' O ' ' N ' ' A' ' 13' ' ' DAL . . . 75.55 -25.69 1.38 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' DBB . . . . . 0.991 ' HA ' ' HG2' ' A' ' 18' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' DAL . . . . . 0.616 ' HB3' ' N ' ' A' ' 19' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.655 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 47.6 mt-10 -43.74 -15.42 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.103 0 CA-C-O 120.878 0.371 . . . . 0.0 110.499 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.815 ' HB2' ' HG3' ' A' ' 12' ' ' DBB . 0.4 OUTLIER -54.4 -33.82 60.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.305 179.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' DBB . . . . . 0.709 ' C ' ' HB2' ' A' ' 20' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.79 ' O ' ' C ' ' A' ' 18' ' ' DBU . . . -16.29 -99.23 0.01 OUTLIER Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.039 -0.825 . . . . 0.0 111.039 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' DBU . . . . . 0.991 ' HG2' ' HA ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.644 ' SG ' ' O ' ' A' ' 19' ' ' CYS . 9.7 p -139.16 50.99 1.8 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.658 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.709 ' HB2' ' C ' ' A' ' 16' ' ' DBB . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.561 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -61.88 -43.07 99.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.768 0.318 . . . . 0.0 110.611 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.552 HD13 ' N ' ' A' ' 4' ' ' ASP . 0.1 OUTLIER -72.26 -14.73 17.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.344 -179.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.584 ' O ' ' CG ' ' A' ' 18' ' ' DBU . 4.6 t0 66.47 43.56 2.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.416 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.565 ' HB3' ' H ' ' A' ' 18' ' ' DBU . 1.4 p -100.83 140.61 21.48 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.403 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.515 ' HA ' ' HB ' ' A' ' 3' ' ' ILE . 39.1 Cg_endo -69.98 18.25 0.2 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.936 2.424 . . . . 0.0 112.149 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.505 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -107.92 -74.09 0.67 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.755 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.562 ' O ' ' C ' ' A' ' 10' ' ' GLY . . . -176.13 172.66 45.65 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.562 ' C ' ' O ' ' A' ' 9' ' ' GLY . . . -27.41 -52.93 0.09 OUTLIER Glycine 0 CA--C 1.518 0.239 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.494 ' O ' ' N ' ' A' ' 13' ' ' DAL . . . -73.78 55.96 2.15 Favored Glycine 0 CA--C 1.523 0.531 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' DBB . . . . . 0.903 ' HA ' ' HG2' ' A' ' 18' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' DAL . . . . . 0.599 ' HB3' ' N ' ' A' ' 19' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 17.6 pt-20 -72.0 -1.86 16.12 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.714 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.542 ' HB2' ' CG ' ' A' ' 12' ' ' DBB . 98.2 mm-40 -70.11 -10.51 59.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.785 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' DBB . . . . . 0.722 ' C ' ' HB2' ' A' ' 20' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.713 ' O ' ' C ' ' A' ' 18' ' ' DBU . . . -6.2 -109.15 0.0 OUTLIER Glycine 0 N--CA 1.466 0.655 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' DBU . . . . . 0.903 ' HG2' ' HA ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.619 ' SG ' ' O ' ' A' ' 19' ' ' CYS . 3.0 p -132.89 40.0 3.27 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.184 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.722 ' HB2' ' C ' ' A' ' 16' ' ' DBB . 0.1 OUTLIER . . . . . 0 C--O 1.221 -0.413 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.835 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.699 ' O ' ' HG1' ' A' ' 18' ' ' DBU . 89.2 mtm-85 -61.13 -41.6 97.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.748 0.309 . . . . 0.0 110.563 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.823 HD13 ' C ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -94.21 -5.22 10.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.458 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -60.35 -43.99 95.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.498 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' DBU . . . . . 0.402 ' C ' ' H ' ' A' ' 18' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.658 ' SG ' ' O ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -118.01 122.45 30.46 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.404 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.13 43.36 1.52 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.761 2.307 . . . . 0.0 112.19 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -121.01 -34.83 3.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.526 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.84 -178.7 47.57 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.48 -40.8 99.19 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.61 -73.97 0.42 Allowed Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' DBB . . . . . 0.799 ' CG ' ' H ' ' A' ' 16' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' DAL . . . . . 0.447 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -69.13 -5.72 24.06 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.799 0.333 . . . . 0.0 110.398 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.615 ' HB2' ' CG ' ' A' ' 12' ' ' DBB . 79.5 mt-30 -61.77 -28.09 69.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' DBB . . . . . 0.799 ' H ' ' CG ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.676 ' O ' ' C ' ' A' ' 18' ' ' DBU . . . -3.03 -115.42 0.0 OUTLIER Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' DBU . . . . . 0.699 ' HG1' ' O ' ' A' ' 2' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.597 ' O ' ' C ' ' A' ' 20' ' ' CYS . 17.5 p -106.52 -29.68 9.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.709 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.735 ' HB2' ' C ' ' A' ' 16' ' ' DBB . 0.8 OUTLIER . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 117.97 -1.015 . . . . 0.0 110.681 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.555 ' HG3' ' CA ' ' A' ' 10' ' ' GLY . 23.8 tpt180 -61.96 -42.78 99.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.294 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.533 HD13 ' H ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -75.37 -15.32 15.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.846 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 1.097 ' O ' ' HG3' ' A' ' 18' ' ' DBU . 68.2 t0 -38.81 123.72 1.3 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.832 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' DBU . . . . . 0.595 ' C ' ' HA3' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.776 ' HB3' ' HG2' ' A' ' 18' ' ' DBU . 0.0 OUTLIER -117.25 104.07 50.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.921 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -84.02 42.94 1.29 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 123.117 2.544 . . . . 0.0 112.381 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.501 ' CB ' ' OE1' ' A' ' 15' ' ' GLN . . . -126.7 -33.06 2.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.681 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.35 172.2 45.01 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.555 ' CA ' ' HG3' ' A' ' 2' ' ' ARG . . . -64.93 -38.32 95.36 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.461 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -61.22 -45.21 96.96 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' DBB . . . . . 0.782 ' O ' ' HB3' ' A' ' 13' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' DAL . . . . . 0.782 ' HB3' ' O ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -78.39 27.55 0.2 Allowed 'General case' 0 C--O 1.231 0.116 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.472 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.642 ' C ' ' HG1' ' A' ' 12' ' ' DBB . 79.6 mt-30 -132.97 -3.77 3.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.553 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' DBB . . . . . 0.675 ' C ' ' HG3' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.67 ' O ' ' O ' ' A' ' 16' ' ' DBB . . . -24.96 160.15 0.0 OUTLIER Glycine 0 CA--C 1.526 0.743 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.859 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' DBU . . . . . 1.097 ' HG3' ' O ' ' A' ' 4' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.62 ' SG ' ' C ' ' A' ' 12' ' ' DBB . 0.1 OUTLIER -98.7 -27.25 14.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 111.422 -2.626 . . . . 0.0 109.908 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.616 ' HB2' ' C ' ' A' ' 16' ' ' DBB . 1.5 m . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.639 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.44 ' HA3' ' CB ' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.493 2.449 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.862 ' HG2' ' HG3' ' A' ' 18' ' ' DBU . 16.5 ttm180 -59.3 -42.79 92.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.981 0.42 . . . . 0.0 110.162 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.533 ' O ' ' O ' ' A' ' 6' ' ' CYS . 5.7 pt -102.07 -0.44 10.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.967 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.44 ' CB ' ' HA3' ' A' ' 1' ' ' GLY . 65.1 t0 -63.02 -43.34 99.01 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.021 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.623 ' SG ' ' HD2' ' A' ' 7' ' ' PRO . 0.3 OUTLIER -78.76 155.11 78.33 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.255 179.794 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.693 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 31.7 Cg_exo -57.56 -25.74 68.67 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 123.147 2.565 . . . . 0.0 112.239 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' A' ' 7' ' ' PRO . . . 100.05 46.85 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.902 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.98 20.9 48.98 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.79 -58.1 3.86 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.535 ' O ' ' C ' ' A' ' 12' ' ' DBB . . . -65.31 -33.69 87.4 Favored Glycine 0 CA--C 1.517 0.168 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' DBB . . . . . 0.797 ' HG3' ' HB2' ' A' ' 15' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' DAL . . . . . 0.644 ' C ' ' N ' ' A' ' 15' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.641 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 49.8 tp10 -41.0 -21.44 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.797 ' HB2' ' HG3' ' A' ' 12' ' ' DBB . 48.2 mt-30 -52.25 -9.74 0.11 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.402 178.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' DBB . . . . . 0.645 ' C ' ' HB2' ' A' ' 20' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.583 ' O ' ' O ' ' A' ' 12' ' ' DBB . . . -24.37 142.19 0.01 OUTLIER Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' DBU . . . . . 0.862 ' HG3' ' HG2' ' A' ' 2' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.552 ' SG ' ' N ' ' A' ' 14' ' ' GLU . 9.6 p -120.49 -7.12 9.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.522 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.645 ' HB2' ' C ' ' A' ' 16' ' ' DBB . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.497 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -64.01 -37.57 87.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.752 0.31 . . . . 0.0 110.463 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.592 HG13 ' N ' ' A' ' 6' ' ' CYS . 0.7 OUTLIER -100.04 1.54 10.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.09 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.78 ' O ' ' HG1' ' A' ' 18' ' ' DBU . 99.0 m-20 63.42 34.08 13.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.391 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' DBU . . . . . 0.672 ' CA ' ' HG3' ' A' ' 18' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.672 ' HB3' ' HG2' ' A' ' 18' ' ' DBU . 1.6 p -114.01 134.35 22.17 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.017 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.479 ' HA ' ' HB ' ' A' ' 3' ' ' ILE . 45.9 Cg_endo -69.69 54.72 1.18 Allowed 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 123.217 2.612 . . . . 0.0 113.332 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.625 ' HB3' ' HB3' ' A' ' 15' ' ' GLN . . . -158.41 -36.81 0.07 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.8 0.333 . . . . 0.0 110.496 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.643 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . 158.71 -168.23 34.86 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.568 ' C ' ' H1 ' ' A' ' 12' ' ' DBB . . . -65.46 170.55 26.8 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.595 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . 74.78 -44.93 1.56 Allowed Glycine 0 CA--C 1.52 0.348 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' DBB . . . . . 0.788 ' O ' ' HB3' ' A' ' 13' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' DAL . . . . . 0.788 ' HB3' ' O ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -78.37 33.07 0.19 Allowed 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.244 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.625 ' HB3' ' HB3' ' A' ' 8' ' ' ALA . 77.8 mt-30 -137.74 -8.22 1.64 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.826 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' DBB . . . . . 0.687 ' O ' ' O ' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.687 ' O ' ' O ' ' A' ' 16' ' ' DBB . . . -26.23 161.47 0.0 OUTLIER Glycine 0 CA--C 1.527 0.8 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.553 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' DBU . . . . . 0.78 ' HG1' ' O ' ' A' ' 4' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.595 ' SG ' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER -99.27 -24.83 14.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 112.954 -1.93 . . . . 0.0 110.237 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.647 ' HB2' ' C ' ' A' ' 16' ' ' DBB . 1.5 m . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.632 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.438 ' O ' ' HG3' ' A' ' 18' ' ' DBU . 80.5 mtt85 -63.37 -41.02 98.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 110.701 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.583 ' O ' HG22 ' A' ' 3' ' ' ILE . 49.3 mm -77.17 -0.98 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.501 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -82.29 111.17 18.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.539 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' DBU . . . . . 0.611 ' C ' ' H ' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.592 ' SG ' ' HD2' ' A' ' 7' ' ' PRO . 4.9 t -101.41 143.49 26.7 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.449 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.736 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 52.6 Cg_exo -51.63 -8.57 0.28 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.874 2.382 . . . . 0.0 112.181 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 7' ' ' PRO . . . 91.37 28.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.496 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.64 16.79 55.61 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.27 -54.99 1.52 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.609 ' O ' ' N ' ' A' ' 13' ' ' DAL . . . -63.24 -35.25 91.82 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' DBB . . . . . 0.747 ' HG2' ' H ' ' A' ' 16' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' DAL . . . . . 0.609 ' N ' ' O ' ' A' ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.603 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 58.1 mp0 -76.5 9.72 2.54 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.856 0.36 . . . . 0.0 110.705 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.68 ' C ' ' HG1' ' A' ' 12' ' ' DBB . 92.3 mm-40 -92.7 -4.69 52.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.044 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' DBB . . . . . 0.784 ' O ' ' HB3' ' A' ' 20' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.611 ' H ' ' C ' ' A' ' 5' ' ' DBU . . . -23.63 142.92 0.01 OUTLIER Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' DBU . . . . . 0.438 ' HG3' ' O ' ' A' ' 2' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.641 ' SG ' ' O ' ' A' ' 19' ' ' CYS . 0.8 OUTLIER -172.33 31.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.609 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.784 ' HB3' ' O ' ' A' ' 16' ' ' DBB . 0.0 OUTLIER . . . . . 0 C--O 1.218 -0.556 0 CA-C-O 117.91 -1.043 . . . . 0.0 110.787 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.583 ' O ' ' CG ' ' A' ' 18' ' ' DBU . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.556 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 80.3 mtp85 -67.27 145.34 55.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.813 0.339 . . . . 0.0 110.572 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 6' ' ' CYS . 30.5 mm 73.4 -16.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.561 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' A' ' 2' ' ' ARG . 67.3 t0 -67.73 108.73 3.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.568 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' DBU . . . . . 0.606 ' C ' ' HA3' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.687 ' SG ' ' O ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -128.91 90.32 46.17 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.488 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.99 -2.83 13.1 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.846 2.364 . . . . 0.0 112.14 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.02 -39.69 72.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.578 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.521 ' O ' HD13 ' A' ' 3' ' ' ILE . . . -165.59 165.04 37.7 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.556 ' O ' ' CB ' ' A' ' 2' ' ' ARG . . . -63.54 -35.04 91.51 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 13' ' ' DAL . . . -62.18 -35.79 92.04 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' DBB . . . . . 0.753 ' HG1' ' C ' ' A' ' 15' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' DAL . . . . . 0.587 ' N ' ' O ' ' A' ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.401 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 59.8 mp0 -71.97 -7.1 46.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.823 0.344 . . . . 0.0 110.581 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.753 ' C ' ' HG1' ' A' ' 12' ' ' DBB . 99.7 mm-40 -70.79 -1.66 12.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.606 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' DBB . . . . . 0.674 ' N ' ' CG ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.606 ' HA3' ' C ' ' A' ' 5' ' ' DBU . . . -35.17 143.51 0.08 OUTLIER Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' DBU . . . . . 0.583 ' CG ' ' O ' ' A' ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.7 p -167.95 20.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.138 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.526 ' HB3' ' O ' ' A' ' 16' ' ' DBB . 1.2 p . . . . . 0 C--O 1.221 -0.423 0 CA-C-O 117.865 -1.064 . . . . 0.0 110.466 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.81 ' O ' ' HG3' ' A' ' 18' ' ' DBU . 29.3 mmt180 -62.58 -43.19 99.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.825 0.345 . . . . 0.0 110.615 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.523 ' CG1' ' HA2' ' A' ' 10' ' ' GLY . 6.1 mt -57.44 -16.2 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.428 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -55.42 -44.05 75.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.283 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.687 ' SG ' ' O ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -118.88 107.35 42.35 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.092 179.458 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.91 14.99 1.38 Allowed 'Trans proline' 0 C--N 1.304 -1.816 0 C-N-CA 122.855 2.37 . . . . 0.0 112.014 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.63 -51.94 6.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.616 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.52 ' C ' HG12 ' A' ' 3' ' ' ILE . . . 172.1 168.72 33.96 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.523 ' HA2' ' CG1' ' A' ' 3' ' ' ILE . . . -41.78 -23.51 0.13 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 9' ' ' GLY . . . -92.88 51.08 2.56 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' DBB . . . . . 1.009 ' HA ' ' HG2' ' A' ' 18' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' DAL . . . . . 0.741 ' HB3' ' H ' ' A' ' 19' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -74.12 -2.47 24.68 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.103 -0.373 . . . . 0.0 110.791 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.647 ' C ' ' HG1' ' A' ' 12' ' ' DBB . 95.6 mm-40 -74.53 -6.0 45.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.566 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' DBB . . . . . 0.716 ' N ' ' CG ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.693 ' O ' ' C ' ' A' ' 18' ' ' DBU . . . -2.4 -116.37 0.0 OUTLIER Glycine 0 C--N 1.338 0.694 0 O-C-N 123.895 0.747 . . . . 0.0 111.285 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' DBU . . . . . 1.009 ' HG2' ' HA ' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.741 ' H ' ' HB3' ' A' ' 13' ' ' DAL . 18.8 p -122.46 -25.8 4.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.58 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.617 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--O 1.219 -0.526 0 CA-C-O 117.924 -1.036 . . . . 0.0 110.612 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.596 ' NH2' ' O ' ' A' ' 10' ' ' GLY . 79.6 mtp85 -62.57 140.07 58.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.809 0.338 . . . . 0.0 110.543 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.565 ' HB ' ' O ' ' A' ' 2' ' ' ARG . 50.6 mm 73.38 -27.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.534 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 56.4 m-20 -63.32 -36.09 82.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.568 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' DBU . . . . . 0.621 ' C ' ' HA3' ' A' ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.695 ' SG ' ' O ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -126.91 92.06 45.49 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.217 179.453 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.436 ' HA ' HG23 ' A' ' 3' ' ' ILE . 55.6 Cg_endo -75.39 -8.48 19.65 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.845 2.364 . . . . 0.0 112.093 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.01 -38.73 91.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.579 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.16 163.52 36.88 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.596 ' O ' ' NH2' ' A' ' 2' ' ' ARG . . . -63.32 -33.7 87.97 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' A' ' 13' ' ' DAL . . . -63.39 -36.7 93.74 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' DBB . . . . . 0.754 ' HG1' ' C ' ' A' ' 15' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' DAL . . . . . 0.558 ' N ' ' O ' ' A' ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.464 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 56.5 mp0 -72.75 -3.42 25.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.81 0.338 . . . . 0.0 110.604 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.754 ' C ' ' HG1' ' A' ' 12' ' ' DBB . 99.1 mm-40 -74.17 -2.6 25.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.541 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' DBB . . . . . 0.708 ' H ' ' HG2' ' A' ' 12' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.621 ' HA3' ' C ' ' A' ' 5' ' ' DBU . . . -28.01 148.63 0.01 OUTLIER Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' DBU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.8 p -149.31 -17.96 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.853 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.54 ' HB3' ' O ' ' A' ' 13' ' ' DAL . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.622 179.796 . . . . . . . . 2 2 . 1 stop_ save_